{"status":"success","message":"All metadata fields for indicator 3-8-1, translated into all languages","data":{"ar":"اخر تحديث","en":"<p>Goal: Ensure healthy lives and promote well-being for all at all ages</p><p>Target: Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all</p><p>Indicator 3.8.1: Coverage of essential health services</p><p>Last updated: March 2020</p><h1>Related indicators as of February 2020</h1>\n<p>The UHC service coverage index is designed to summarize existing indicators of health service coverage to ensure consistency with the SDGs and other global initiatives and reduce duplication and reporting burden. Currently, two other SDG indicators are included in the index (3.a.1 and 3.d.1). </p>\n<p>Indicator 3.8.1 should always be interpreted together with the other SDG UHC indicator, 3.8.2, which measures financial protection.</p><h1>Institutional information</h1>\n<h2>Organization(s):</h2>\n<p>World Health Organization (WHO) </p><h1>Concepts and definitions</h1>\n<h2>Definition:</h2>\n<p>Coverage of essential health services (defined as the average coverage of essential services based on tracer interventions that include reproductive, maternal, newborn and child health, infectious diseases, non-communicable diseases and service capacity and access, among the general and the most disadvantaged population).</p>\n<p>The indicator is an index reported on a unitless scale of 0 to 100, which is computed as the geometric mean of 14 tracer indicators of health service coverage.</p>\n<h2>Concepts:</h2>\n<p>The index of health service coverage is computed as the geometric means of 14 tracer indicators. The 14 indicators are listed below and detailed metadata for each of the components are given online (<a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf\">http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf</a>) and Annex 1. The tracer indicators are as follows, organized by four broad categories of service coverage:</p>\n<p><strong><em>I. Reproductive, maternal, newborn and child health</em></strong></p>\n<p>1. <strong>Family planning</strong>: Percentage of women of reproductive age (15&#x2212;49 years) who are married or in-union who have their need for family planning satisfied with modern methods </p>\n<p>2. <strong>Pregnancy and delivery care</strong>: Percentage of women aged 15-49 years with a live birth in a given time period who received antenatal care four or more times</p>\n<p>3. <strong>Child immunization</strong>: Percentage of infants receiving three doses of diphtheria-tetanus-pertussis containing vaccine</p>\n<p>4. <strong>Child treatment</strong>: Percentage of children under 5 years of age with suspected pneumonia (cough and difficult breathing NOT due to a problem in the chest and a blocked nose) in the two weeks preceding the survey taken to an appropriate health facility or provider</p>\n<p><strong><em>II. Infectious diseases</em></strong></p>\n<p>5. <strong>Tuberculosis</strong>: Percentage of incident TB cases that are detected and successfully treated</p>\n<p>6. <strong>HIV/AIDS</strong>: Percentage of people living with HIV currently receiving antiretroviral therapy</p>\n<p>7. <strong>Malaria</strong>: Percentage of population in malaria-endemic areas who slept under an insecticide-treated net the previous night [only for countries with high malaria burden]</p>\n<p>8. <strong>Water and sanitation</strong>: Percentage of households using at least basic sanitation facilities</p>\n<p><strong><em>III. Noncommunicable diseases</em></strong></p>\n<p>9. <strong>Hypertension</strong>: Age-standardized prevalence of non-raised blood pressure (systolic blood pressure &lt;140 mm Hg or diastolic blood pressure &lt;90 mm Hg) among adults aged 18 years and older</p>\n<p>10. <strong>Diabetes</strong>: Age-standardized mean fasting plasma glucose (mmol/L) for adults aged 18 years and older</p>\n<p>11. <strong>Tobacco</strong>: Age-standardized prevalence of adults &gt;=15 years not smoking tobacco in last 30 days (SDG indicator 3.a.1, metadata available <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0a-01.pdf\">here</a>)</p>\n<p><strong><em>IV. Service capacity and access</em></strong></p>\n<p>12. <strong>Hospital access</strong>: Hospital beds per capita, relative to a maximum threshold of 18 per 10,000 population</p>\n<p>13. <strong>Health workforce</strong>: Health professionals (physicians, psychiatrists, and surgeons) per capita, relative to maximum thresholds for each cadre (partial overlap with SDG indicator 3.c.1, see metadata <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0C-01.pdf\">here</a>)</p>\n<p>14. <strong>Health security</strong>: International Health Regulations (IHR) core capacity index, which is the average percentage of attributes of 13 core capacities that have been attained (SDG indicator 3.d.1, see metadata <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0D-01.pdf\">here</a>)</p><h1>Data sources</h1>\n<h2>Description:</h2>\n<p>Many of the tracer indicators of health service coverage are measured by household surveys. However, administrative data, facility data, facility surveys, and sentinel surveillance systems are utilized for certain indicators. Underlying data sources for each of the 14 tracer indicators are explained in more detail in Annex 1.</p>\n<p>In terms of values used to compute the index, values are taken from existing published sources. This includes assembled data sets and estimates from various UN agencies. This is summarized in the above link.</p><h2>Collection process:</h2>\n<p>The mechanisms for collecting data from countries vary across the 14 tracer indicators, however in many cases a UN agency or interagency group has assembled and analysed relevant national data sources and then conducted a formal country consultation with country governments to review or produce comparable country estimates. For the UHC service coverage index, once this existing information on the 14 tracer indicators is collated, WHO conducts a country consultation with nominated focal points from national governments to review inputs and the calculation of the index. WHO does not undertake new estimation activities to produce tracer indicator values for the service coverage index; rather, the index is designed to make use of existing and well-established indicator data series to reduce reporting burden.</p><h1>Calendar</h1>\n<h2>Data collection:</h2>\n<p>Data collection varies from every 1 to 5 years across tracer indicators. For example, country data on immunizations and HIV treatment are reported annually, whereas household surveys to collect information on child treatment may occur every 3-5 years, depending on the country. More details about individual tracer indicators are available in Annex 1.</p><h2>Data release:</h2>\n<p>The first release of baseline values for the UHC service coverage index took place in December 2017. It is anticipated that an update will be released in September, 2019. </p><h1>Data providers</h1>\n<p>In most cases, Ministries of Health and National Statistical Offices oversee data collection and reporting for health service coverage indicators.</p><h1>Data compilers</h1>\n<p>The World Health Organization, drawing on inputs from other international agencies.</p><h2>Rationale:</h2>\n<p>Target 3.8 is defined as &#x201C;Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all&#x201D;. The concern is with all people and communities receiving the quality health services they need (including medicines and other health products), without financial hardship. Two indicators have been chosen to monitor target 3.8 within the SDG framework. Indicator 3.8.1 is for health service coverage and indicator 3.8.2 focuses on health expenditures in relation to a household&#x2019;s budget to identify financial hardship caused by direct health care payments. Taken together, indicators 3.8.1 and 3.8.2 are meant to capture the service coverage and financial protection dimensions, respectively, of target 3.8. These two indicators should be always monitored jointly.</p>\n<p>Countries provide many essential services for health protection, promotion, prevention, treatment and care. Indicators of service coverage &#x2013; defined as people receiving the service they need &#x2013; are the best way to track progress in providing services under universal health coverage (UHC). Since a single health service indicator does not suffice for monitoring UHC, an index is constructed from 14 tracer indicators selected based on epidemiological and statistical criteria. This includes several indicators that are already included in other SDG targets, thereby minimizing the data collection and reporting burden. The index is reported on a unitless scale of 0 to 100, with 100 being the optimal value.</p><h2>Comments and limitations:</h2>\n<p>These tracer indicators are meant to be indicative of service coverage, not a complete or exhaustive list of health services and interventions that are required for universal health coverage. The 14 tracer indicators were selected because they are well-established, with available data widely reported by countries (or expected to become widely available soon). Therefore, the index can be computed with existing data sources and does not require initiating new data collection efforts solely to inform the index.</p><h1>Methodology</h1>\n<p><strong>Computation method:</strong></p>\n<p>The index is computed with geometric means, based on the methods used for the Human Development Index. The calculation of the 3.8.1 indicator requires first preparing the 14 tracer indicators so that they can be combined into the index, and then computing the index from those values. </p>\n<p>The 14 tracer indicators are first all placed on the same scale, with 0 being the lowest value and 100 being the optimal value. For most indicators, this scale is the natural scale of measurement, e.g., the percentage of infants who have been immunized ranges from 0 to 100 percent. However, for a few indicators additional rescaling is required to obtain appropriate values from 0 to 100, as follows:</p>\n<ul>\n  <li>Rescaling based on a non-zero minimum to obtain finer resolution (this &#x201C;stretches&#x201D; the distribution across countries): prevalence of non-raised blood pressure and prevalence of non-use of tobacco are both rescaled using a minimum value of 50%.<ul>\n      <li>rescaled value = (X-50)/(100-50)*100</li>\n    </ul>\n  </li>\n  <li>Rescaling for a continuous measure: mean fasting plasma glucose, which is a continuous measure (units of mmol/L), is converted to a scale of 0 to 100 using the minimum theoretical biological risk (5.1 mmol/L) and observed maximum across countries (7.1 mmol/L).<ul>\n      <li>rescaled value = (7.1 - original value)/(7.1-5.1)*100</li>\n    </ul>\n  </li>\n  <li>Maximum thresholds for rate indicators: hospital bed density and health workforce density are both capped at maximum thresholds, and values above this threshold are held constant at 100. These thresholds are based on minimum values observed across OECD countries.<ul>\n      <li>rescaled hospital beds per 10,000 = minimum(100, original value / 18*100)</li>\n      <li>rescaled physicians per 1,000 = minimum(100, original value / 0.9*100)</li>\n      <li>rescaled psychiatrists per 100,000 = minimum(100, original value / 1*100)</li>\n      <li>rescaled surgeons per 100,000 = minimum(100, original value / 14*100)</li>\n    </ul>\n  </li>\n</ul>\n<p>Once all tracer indicator values are on a scale of 0 to 100, geometric means are computed within each of the four health service areas, and then a geometric mean is taken of those four values. If the value of a tracer indicator happens to be zero, it is set to 1 (out of 100) before computing the geometric mean. The following diagram illustrates the calculations.</p>\n<p><img src=\"data:image/png;base64,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\"></p>\n<p>Note that in countries with low malaria burden, the tracer indicator for use of insecticide-treated nets is dropped from the calculation.</p><h2>Treatment of missing values:</h2>\n<ul>\n  <li><strong><em>At country level:</em></strong></li>\n</ul>\n<p>The starting point for computing the index is to assemble existing information for each tracer indicator. In many cases, this involves using country time series that have been produced or collated by UN agencies in consultation with country governments (e.g., immunization coverage, access to sanitation, HIV treatment coverage, etc). Some of these published time series involve mathematical modelling to reconcile multiple data sources or impute missing values, and these details are summarized in Annex 1. </p>\n<p>After assembling these inputs, there are still missing values for some country-years for some indicators. Calculating the UHC service coverage index requires values for each tracer indicator for a country, so some imputation is necessary to fill these data gaps. The current approach involves a simple imputation algorithm. For each indicator:</p>\n<ul>\n  <li>\n    <ul>\n      <li>If a country has missing values between two years with values, linear interpolation is used to fill missing values for the intervening years</li>\n      <li>If a country has historical years with values, but no current value, constant extrapolation is used to fill missing values to the current year</li>\n      <li>If a country has no values, a value is imputed. For pneumonia care-seeking and density of surgeons, a regression is fit to impute missing values (see Annex 1 for details). For all other indicators, a regional median is calculated to impute missing values. Regions are based on World Bank geographic regions, with a separate grouping of traditional high-income countries<sup><a href=\"#footnote-1\" id=\"footnote-ref-1\">[1]</a></sup> </li>\n    </ul>\n  </li>\n</ul>\n<p>Given the timing and distribution of various health surveys and other data collection mechanisms, countries do not collect and report on all 14 tracer indicators of health service coverage on an annual basis. In addition, monitoring at country level is most suitably done at broader time intervals, e.g., every 5 years, to allow for new data collection across indicators. Therefore, the extent to which imputation has been used to fill missing information should be communicated along with the index value. </p>\n<ul>\n  <li><strong><em>At regional and global levels:</em></strong></li>\n</ul>\n<p>Any needed imputation is done at country level. These country values can then be used to compute regional and global ones.</p><div class=\"footnotes\"><div><sup class=\"footnote-number\" id=\"footnote-1\">1</sup><p> Argentina, Australia, Austria, Belgium, Brunei Darussalam, Canada, Chile, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Japan, Luxembourg, Malta, Netherlands, New Zealand, Norway, Poland, Portugal, Republic of Korea, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States of America, Uruguay <a href=\"#footnote-ref-1\">&#x2191;</a></p></div></div><h2>Regional aggregates:</h2>\n<p>Regional and global aggregates are computed by using national population sizes to compute a weighted average of country-specific values for the index. This is justified on the grounds that UHC is a property of countries, and the index of essential services is a summary measure of access to essential services for each country&#x2019;s population.</p><h1>Data availability</h1>\n<h2>Description:</h2>\n<p>Summarizing data availability for the UHC service coverage index is not straightforward, as different data sources are used across the 14 tracer indicators. Additionally, for many indicators comparable estimates have been produced, in many cases drawing on different types of underlying data sources to inform the estimates while also using projections to impute missing values. Based on the underlying data sources for each of the tracer indicators (i.e., ignoring estimates and projections), the average proportion of indicators used to compute the index with underlying data available since 2010 is around 70% across countries globally.</p>\n<h2>Time series:</h2>\n<p>A baseline value for the UHC service coverage index for 2015 across 183 countries was published in late 2017. As part of this process, data sources going back to 2000 were assembled. In 2019, it is anticipated to publish a time series from 2000 to 2017.</p>\n<h2>Disaggregation:</h2>\n<p>Equity is central to the definition of UHC, and therefore the UHC service coverage index should be used to communicate information about inequalities in service coverage within countries. This can be done by presenting the index separately for the national population vs disadvantaged populations to highlight differences between them. </p>\n<p>For countries, geographic location is likely the most feasible dimension for sub-national disaggregation based on average coverage levels measured with existing data sources. To do this, the UHC index can be computed separately by, e.g., province or urban vs rural residence, which would allow for subnational comparisons of service coverage. Currently, the most readily available data for disaggregation on other dimensions of inequality, such as household wealth, is for indicators of coverage within the reproductive, maternal, newborn and child health services category. Inequality observed in this dimension can be used as a proxy to understand differences in service coverage across key inequality dimensions. This approach should be replaced with full disaggregation of all 14 tracer indicators once data are available to do so.</p><h2>Sources of discrepancies:</h2>\n<p>The service coverage index draws on existing, publicly available data and estimates for tracer indicators. These numbers have already been through a country consultation process (e.g., for immunization coverage), or are taken directly from country reported data. </p><h1>References</h1>\n<h2><strong>URL: </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<h2><strong>References: </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/</a></p>\n<p><a href=\"http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf\">http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<p>For historical development of methods, see:</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1\">http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1</a> (superseded by this document)</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/</a></p>\n<p><a href=\"http://collections.plos.org/uhc2014\">http://collections.plos.org/uhc2014</a></p>\n<h1>Annex 1: Metadata for tracer indicators used to measure the coverage of essential health services for monitoring SDG indicator 3.8.1.</h1>\n<p>Please send any comments or queries to: <a href=\"mailto:uhc_stats@who.int\">uhc_stats@who.int</a></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Family planning</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of women of reproductive age (15&#x2212;49 years) who are married or in-union who have their need for family planning satisfied with modern methods.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of women aged 15-49 who are married or in-union who use modern methods</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total number of women aged 15-49 who are married or in-union in need of family planning</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Population-based health surveys</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Household surveys include a series of questions to measure modern contraceptive prevalence rate and demand for family planning. Total demand for family planning is defined as the sum of the number of women of reproductive age (15&#x2013;49 years) who are married or in a union and who are currently using, or whose sexual partner is currently using, at least one contraceptive method, and the unmet need for family planning. Unmet need for family planning is the proportion of women of reproductive age (15&#x2013;49 years) either married or in a consensual union, who are fecund and sexually active but who are not using any method of contraception (modern or traditional), and report not wanting any more children or wanting to delay the birth of their next child for at least two years. Included are:</p>\n        <p>all pregnant women (married or in a consensual union) whose pregnancies were unwanted or mistimed at the time of conception;</p>\n        <p>all postpartum amenorrhoeic women (married or in consensual union) who are not using family planning and whose last birth was unwanted or mistimed;</p>\n        <p>all fecund women (married or in consensual union) who are neither pregnant nor postpartum amenorrhoeic, and who either do not want any more children (want to limit family size), or who wish to postpone the birth of a child for at least two years or do not know when or if they want another child (want to space births), but are not using any contraceptive method.</p>\n        <p>Modern methods include female and male sterilization, the intra-uterine device (IUD), the implant, injectables, oral contraceptive pills, male and female condoms, vaginal barrier methods (including the diaphragm, cervical cap and spermicidal foam, jelly, cream and sponge), lactational amenorrhea method (LAM), emergency contraception and other modern methods not reported separately.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>The United Nations Population Division produces a systematic and comprehensive series of annual estimates and projections of the percentage of demand for family planning that is satisfied among married or in-union women. A Bayesian hierarchical model combined with country-specific data are used to generate the estimates, projections and uncertainty assessments from survey data. The model accounts for differences by data source, sample population, and contraceptive methods. </p>\n        <p>See here for details: <a href=\"http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml\">http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td></td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Pregnancy and delivery care</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of women aged 15-49 years with a live birth in a given time period who received antenatal care four or more times </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of women aged 15&#x2212;49 years with a live birth in a given time period who received antenatal care four or more times</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total number of women aged 15&#x2212;49 years with a live birth in the same period.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Household surveys and routine facility information systems.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Data on four or more antenatal care visits is based on questions that ask if and how many times the health of the woman was checked during pregnancy. Household surveys that can generate this indicator include DHS, MICS, RHS and other surveys based on similar methodologies. Service/facility reporting systems can be used where the coverage is high, usually in higher income countries.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>WHO maintains a data base on coverage of antenatal care: <a href=\"http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4\">http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>Ideally this indicator would be replaced with a more comprehensive measure of pregnancy and delivery care, for example the proportion of women who have a skilled provider attend the birth or an institutional delivery. A challenge in measuring skilled attendance at birth is determining which providers are &#x201C;skilled&#x201D;. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<p><br></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Child immunization</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of infants receiving three doses of diphtheria-tetanus-pertussis containing vaccine</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Children 1 year of age who have received three doses of diphtheria-tetanus-pertussis containing vaccine</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>All children 1 year of age</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Household surveys and facility information systems.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>For survey data, the vaccination status of children aged 12&#x2013;23 months is collected from child health cards or, if there is no card, from recall by the care-taker. For administrative data, the total number of doses administered to the target population is extracted.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>Together, WHO and UNICEF derive estimates of DTP3 coverage based on data officially reported to WHO and UNICEF by Member States, as well as data reported in the published and grey literature. They also consult with local experts - primarily national EPI managers and WHO regional office staff - for additional information regarding the performance of specific local immunization services. Based on the available data, consideration of potential biases, and contributions from local experts, WHO/UNICEF determine the most likely true level of immunization coverage. </p>\n        <p>For details, see here: </p>\n        <p><a href=\"http://www.who.int/bulletin/volumes/87/7/08-053819/en/\">http://www.who.int/bulletin/volumes/87/7/08-053819/en/</a></p>\n        <p><a href=\"http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html\">http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>There is variability in national vaccine schedules across countries. Given this, one option for monitoring full child immunization is to monitor the fraction of children receiving vaccines included in their country&#x2019;s national schedule. A second option, which may be more comparable across countries and time, is to monitor DTP3 coverage as a proxy for full child immunization. Diphtheria-tetanus-pertussis containing vaccine often includes other vaccines, e.g., against Hepatitis B and Haemophilus influenza type B, and is a reasonable measure of the extent to which there is a robust vaccine delivery platform within a country. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Child treatment (care-seeking for symptoms of pneumonia)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of children under 5 years of age with suspected pneumonia (cough and difficult breathing NOT due to a problem in the chest and a blocked nose) in the two weeks preceding the survey taken to an appropriate health facility or provider.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of children with suspected pneumonia in the two weeks preceding the survey taken to an appropriate health provider.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Number of children with suspected pneumonia in the two weeks preceding the survey.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Household surveys</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>During the UNICEF/WHO Meeting on Child Survival Survey-based Indicators, held in New York, 17&#x2013;18 June 2004, it was recommended that acute respiratory infections (ARI) be described as &#x201C;presumed pneumonia&#x201D; to better reflect probable cause and the recommended interventions. The definition of presumed pneumonia used in the Demographic and Health Surveys (DHS) and in the Multiple Indicator Cluster Surveys (MICS) was chosen by the group and is based on mothers&#x2019; perceptions of a child who has a cough, is breathing faster than usual with short, quick breaths or is having difficulty breathing, excluding children that had only a blocked nose. The definition of &#x201C;appropriate&#x201D; care provider varies between countries.</p>\n        <p>WHO maintains a data base of country-level observations from household surveys that can be accessed here: <a href=\"http://apps.who.int/gho/data/node.main.38?lang=en\">http://apps.who.int/gho/data/node.main.38?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>There are currently no internationally comparable estimates for this indicator.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>This indicator is not typically measured in higher income countries with well-established health systems. </p>\n        <p>For countries without observed data, coverage was estimated from a regression that predicts coverage of care-seeking for symptoms of pneumonia (on the logit scale), obtained from the WHO data base described above, as a function of the log of the estimated under-five pneumonia mortality rate, which can be found here: <a href=\"https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html\">https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html</a></p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Tuberculosis treatment</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of incidence TB cases that are detected and successfully treated in a given year</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of new and relapse cases detected in a given year and successfully treated</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Number of new and relapse cases in the same year</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Facility information systems, surveillance systems, population-based health surveys with TB diagnostic testing, TB register and related quarterly reporting system (or electronic TB registers)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>This indicator requires three main inputs:</p>\n        <p>(1) The number of new and relapse TB cases diagnosed and treated in national TB control programmes and notified to WHO in a given year.</p>\n        <p>(2) The number of incident TB cases for the same year, typically estimated by WHO.</p>\n        <p>(3) Percentage of TB cases successfully treated (cured plus treatment completed) among TB cases notified to the national health authorities.</p>\n        <p>The final indicator = (1)/(2) x (3)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>Estimates of TB incidence are produced through a consultative and analytical process led by WHO and are published annually. These estimates are based on annual case notifications, assessments of the quality and coverage of TB notification data, national surveys of the prevalence of TB disease and information from death (vital) registration systems. Estimates of incidence for each country are derived, using one or more of the following approaches depending on available data:</p>\n        <p>1. incidence = case notifications/estimated proportion of cases detected;</p>\n        <p>2. incidence = prevalence/duration of condition;</p>\n        <p>3. incidence = deaths/proportion of incident cases that die. </p>\n        <p>These estimates of TB incidence are combined with country-reported data on the number of cases detected and treated, and the percentage of cases successfully treated, as described above.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>To compute the indicator using WHO estimates, one can access necessary files here: <a href=\"http://www.who.int/tb/country/data/download/en/\">http://www.who.int/tb/country/data/download/en/</a>, and compute the indicator as = c_cdr x c_new_tsr</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>HIV treatment</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of people living with HIV currently receiving antiretroviral therapy (ART)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of adults and children who are currently receiving ART at the end of the reporting period</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Number of adults and children living with HIV during the same period</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Facility reporting systems, sentinel surveillance sites, population-based surveys</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Numerator: The numerator can be generated by counting the number of adults and children who received antiretroviral combination therapy at the end of the reporting period. Data can be collected from facility-based ART registers or drug supply management systems. These are then tallied and transferred to cross sectional monthly or quarterly reports which can then be aggregated for national totals. Patients receiving ART in the private sector and public sector should be included in the numerator.</p>\n        <p>Denominator: Data on the number of people with HIV infection may come from population-based surveys or, as is common in sub-Saharan Africa, surveillance systems based on antenatal care clinics.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>Estimates of antiretroviral treatment coverage among people living with HIV for 2000-2018 are derived as part of the 2019 UNAIDS&apos; estimation round. </p>\n        <p>To estimate the number of people living with HIV across time in high burden countries, UNAIDS in collaboration with countries uses an epidemic model (Spectrum) that combines surveillance data on prevalence with the current number of patients receiving ART and assumptions about the natural history of HIV disease progression. </p>\n        <p>Since ART is now recommended for all individuals living with HIV, monitoring ART coverage is less complicated than before, when only those with a certain level of disease severity were eligible to receive ART.</p>\n        <p>Estimates of ART coverage can be found here: http://aidsinfo.unaids.org/</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>Comparable estimates of ART coverage in high income countries, in particular time trends, are not always available.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Malaria prevention</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of population in malaria-endemic areas who slept under an ITN the previous night.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of people in malaria-endemic areas who slept under an ITN.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total number of people in malaria endemic areas.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Data on household access and use of ITNs come from nationally representative household surveys such as Demographic and Health Surveys, Multiple Indicator Cluster Surveys, and Malaria Indicator Surveys. Data on the number of ITNs delivered by manufacturers to countries are compiled by Milliner Global Associates, and data on the number of ITNs distributed within countries are reported by National Malaria Control Programs.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Many recent national surveys report the number of ITNs observed in each respondent household. Ownership rates can be converted to the proportion of people sleeping under an ITN using a linear relationship between access and use that has been derived from 62 surveys that collect information on both indicators. </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>Mathematical models can be used to combine data from household surveys on access and use with information on ITN deliveries from manufacturers and ITN distribution by national malaria programmes to produce annual estimates of ITN coverage. WHO uses this approach in collaboration with the Malaria Atlas Project. Methodological details can be found in the Annex of the World Malaria Report 2015: <a href=\"http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/\">http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>WHO produces comparable ITN coverage estimates for 40 high burden countries. For other countries, ITN coverage is not included in the UHC service coverage index due to data limitations. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Water and sanitation</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Percentage of households using at least basic sanitation facilities</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Population living in a household with: flush or pour-flush to piped sewer system, septic tank or pit latrine; ventilated improved pit latrine; pit latrine with slab; or composting toilet.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total population</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Population-based household surveys and censuses</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Household-level responses, weighted by household size, are used to compute population coverage.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>The WHO/UNICEF Joint Monitoring Programme has produced regular estimates of coverage of at least basic sanitation for MDG monitoring. After compiling a database of available data sources, for each country, simple linear regressions are fitted to the country&#x2019;s data series to obtain an in-sample estimate, as well as to produce a 2-year extrapolation beyond the last available data point, after which coverage is held constant for 4 years and then assumed missing. This is done separately for urban and rural regions, and then combined to obtain national coverage estimates. Details of the methodology and most recent estimates can be found here: http://www.wssinfo.org/</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>The SDG indicator for sanitation (SDG 6.2.1) is an expanded version of the MDG indicator, incorporating the quality of sanitation facilities. It is not for UHC monitoring due to lower data availability. A joint indicator that identifies the proportion of households with access to both safe water and sanitation could also be considered.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Prevention of cardiovascular disease</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Age-standardized prevalence of normal blood pressure among adults aged 18+, regardless of treatment status</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of adults aged 18 or older with systolic blood pressure &lt;140 mm Hg and diastolic blood pressure &lt;90 mm Hg (regardless of treatment status)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Number of adults aged 18 or older</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Population-based surveys and surveillance systems</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Data sources recording measured blood pressure are used (self-reported data are excluded).&#xA0;If multiple blood pressure readings are taken per participant, the first reading is dropped and the remaining readings are averaged.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>For producing comparable national estimates, data observations of prevalence defined in terms of alternate SBP and/or DBP cutoffs are converted into prevalence of raised blood pressure, defined as systolic blood pressure &gt;=140 mm Hg or diastolic blood pressure &gt;=90 mm Hg using regression equations. A Bayesian hierarchical model is then fitted to these data to calculate age-sex-year-country specific prevalences, which accounts for national vs. subnational data sources, urban vs. rural data sources, and allows for variation in prevalence across age and sex. Age-standardized estimates are then produced by applying the crude estimates to the WHO Standard Population. Details on the statistical methods are here: <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext</a></p>\n        <p>WHO and the NCD Risk Factor Collaboration (NCD-RisC) has produced comparable estimates for this indicator up through year 2015, which are available here: </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en\">http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>Prevalence estimates are converted to the prevalence of normal blood pressure for incorporation into the UHC index, so that a value of 100% is the optimal target. This is computed as: normal blood pressure prevalence = 1 &#x2013; raised blood pressure prevalence. The above estimates are done separately for men and women; for the UHC tracer indicator a simple average of values for men and women is computed.</p>\n        <p>Normal blood pressure is the sum of the percentage of individuals who do not have hypertension, and the percentage of individuals whose hypertension is controlled by medication. The absence of hypertension is a result of prevention efforts via promotion of physical activity and healthy diets, as well as other factors. Hypertension controlled with medication is a result of effective treatment. This indicator is thus a proxy for both effective health promotion and effective medical services. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Management of diabetes</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Age-standardized mean fasting plasma glucose for adults aged 18 years and older</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Population-based surveys and surveillance systems</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Fasting plasma glucose (FPG) levels are determined by taking a blood sample from participants who have fasted for at least 8 hours. Other related biomarkers, such as hemoglobin A1c (HbA1c), were used to help calculate estimates (see below).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>For producing comparable national estimates, data observations based on mean FPG, oral glucose tolerance test (OGTT), HbA1c, or combinations therein, are all converted to mean FPG. A Bayesian hierarchical model is then fitted to these data to calculate age-sex-year-country specific prevalences, which accounts for national vs. subnational data sources, urban vs. rural data sources, and allows for variation in prevalence across age and sex. Age-standardized estimates are then produced by applying the crude estimates to the WHO Standard Population. Methodological details can be found here: <a href=\"https://www.who.int/diabetes/global-report/en/\">https://www.who.int/diabetes/global-report/en/</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>An individual&#x2019;s FPG may be low because of effective treatment with glucose-lowering medication, or because the individual is not diabetic as a result of health promotion activities or other factors such as genetics. Mean FPG is thus a proxy for both effective promotion of healthy diets and behaviors and effective treatment of diabetes. </p>\n        <p>The above estimates are done separately for men and women; for the UHC tracer indicator a simple average of values for men and women is computed.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Tobacco control</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Age-standardized prevalence of adults &gt;=15 years not smoking tobacco in last 30 days </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Adults 15 years and older who have not smoked tobacco in the last 30 days</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Adults 15 years and older</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Household surveys</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>&#x201C;Current tobacco smoking&quot; includes cigarettes, cigars, pipes or any other smoked tobacco products used in the past 30 days. Data are collected via self-report in surveys.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>WHO estimates prevalence of current tobacco (non) smoking with a negative binomial meta-regression model, which generates comparable estimates by adjusting for differences in age groups and indicator definition across national surveys included in the analysis. These estimates are done separately for men and women. Methodological details can be found here: <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>Prevalence of not smoking tobacco is computed as 1 minus the prevalence of tobacco smoking.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Hospital access</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Hospital beds per capita, relative to a maximum threshold of 18 per 10,000 population</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of hospital beds (should exclude labor and delivery beds)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total population</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Administrative systems / Health facility reporting system</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Country administrative systems are used to total the number of hospital beds, which are divided by the total estimated population, and multiplied by 10,000. </p>\n        <p>WHO regional offices and other groups collect information on national hospital bed density, including the following online resources:</p>\n        <p><a href=\"https://rho.emro.who.int/rhodata/node.main.A36\">https://rho.emro.who.int/rhodata/node.main.A36</a></p>\n        <p>WHO AFRO regional observatory: <a href=\"http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population\">http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population</a></p>\n        <p>WHO EURO European Health for All Database: <a href=\"https://gateway.euro.who.int/en/datasets%20european-health-for-all-database/\">https://gateway.euro.who.int/en/datasets european-health-for-all-database/</a></p>\n        <p>OECD: <a href=\"https://data.oecd.org/healtheqt/hospital-beds.htm\">https://data.oecd.org/healtheqt/hospital-beds.htm</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>Using available data, the indicator is computed relative to a threshold value of 18 hospital beds per 10,000 population. This threshold is below the observed OECD high income country minimum (since year 2000) of 20 per 10,000 and tends to correspond to an inpatient hospital admission rate of around 5 per 100 per year. This indicator is designed to capture low levels of hospital capacity; the maximum threshold is used because very high hospital bed densities are not necessary an efficient use of resources. The indicator is computed as follows, using country data on hospital bed density (<em>x</em>), which results in values ranging from 0 to 100:</p>\n        <p>Country with a hospital bed density <em>x</em> &lt; 18 per 10,000 per year, the indicator = </p>\n        <p><em>x</em> /18*100. </p>\n        <p>Country with a hospital bed density <em>x</em> &gt;= 18 per 10,000 per year, the indicator = 100.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>An alternative indicator could be hospital in-patient admission rate, relative to a maximum threshold. However, that indicator is currently not reported widely across regions, in particular the African Region. In countries where both hospital beds per capita and in-patient admission rates are available, they are highly correlated.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Health workforce</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Health professionals (physicians, psychiatrists, and surgeons) per capita, relative to maximum thresholds for each cadre</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of physicians, psychiatrists and surgeons</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total population</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>National database or registry of health workers, ideally coupled with regular assessment of completeness using census data, professional association registers, or facility censuses.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>The classification of health workers is based on criteria for vocational education and training, regulation of health professions, and activities and tasks of jobs, i.e., a framework for categorizing key workforce variables according to shared characteristics. The WHO framework largely draws on the latest revisions to the internationally standardized classification systems of the International Labour Organization (International Standard Classification of Occupations), United Nations Educational, Scientific and Cultural Organization (International Standard Classification of Education), and the United Nations Statistics Division (International Standard Industrial Classification of All Economic Activities). </p>\n        <p>Methodological details and data can be found here: <a href=\"http://www.who.int/hrh/statistics/hwfstats/en/\">http://www.who.int/hrh/statistics/hwfstats/en/</a></p>\n        <p>Data are from the following sources:</p>\n        <p>Physicians: <a href=\"http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en\">http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en</a></p>\n        <p>Psychiatrists: <a href=\"https://www.who.int/healthinfo/universal_health_coverage/report/2017/en/\">https://www.who.int/healthinfo/universal_health_coverage/report/2017/en/</a></p>\n        <p>Surgeons: <a href=\"http://apps.who.int/gho/data/node.main.HWF9?lang=en%20\">http://apps.who.int/gho/data/node.main.HWF9?lang=en</a> </p>\n        <p>(data here were supplemented by prior editions of the the database)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>Using available data, the indicator is computed by first rescaling, separately, health worker density ratios for each of the three cadres (physicians, psychiatrists and surgeons) relative to the minimum observed values across OECD countries since 2000, which are as follows: physicians = 0.9 per 1000, psychiatrists = 1 per 100,000, and surgeons = 14 per 100,000. This rescaling is done in the same way as that for the hospital bed density indicator described above, resulting in indicator values that range from 0 to 100 for each of the three cadres. For example, using country data on physicians per 1000 population (<em>x</em>), the cadre-specific indicator would be computed as:</p>\n        <p>Country with <em>x</em> &lt; 0.9 per 1000 per year, the cadre-specific indicator = <em>x</em> /0.9*100. </p>\n        <p>Country with <em>x</em> &gt;= 0.9 per 1000 per year, the cadre-specific indicator = 100.</p>\n        <p>As a final step, the geometric mean of the three cadre-specific indicator values is computed to obtain the final indicator of health workforce density.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>The &#x201C;physicians&#x201D; category would ideally be expanded to include all &#x201C;core health professionals&#x201D;, such as nurses and midwives. However, no internationally comparable data base exists that uses consistent definitions of non-physician core health professionals to allow for fully accurate cross-country comparisons. </p>\n        <p>For countries without observed data, the density of surgeons was estimated from a regression that predicts the log of surgeons per 100,000, obtained from the WHO data base described above, as a function of the log of GDP per capita, as estimated by the World Bank.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Tracer area</p>\n      </td>\n      <td>\n        <p>Health security</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>International Health Regulations (IHR) core capacity index, which is the average percentage of attributes of 13 core capacities that have been attained at a specific point in time. </p>\n        <p>The 13 core capacities are: (1) National legislation, policy and financing; (2) Coordination and National Focal Point communications; (3) Surveillance; (4) Response; (5) Preparedness; (6) Risk communication; (7) Human resources; (8) Laboratory; (9) Points of entry; (10) Zoonotic events; (11) Food safety; (12) Chemical events; (13) Radionuclear emergencies.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerator</p>\n      </td>\n      <td>\n        <p>Number of attributes attained</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominator</p>\n      </td>\n      <td>\n        <p>Total number of attributes</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Main data sources</p>\n      </td>\n      <td>\n        <p>Key informant survey</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of measurement</p>\n      </td>\n      <td>\n        <p>Key informants report on attainment of a set of attributes for each of 13 core capacities using a standard WHO instrument, as described here: <a href=\"http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf\">http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf</a></p>\n        <p>Capacity-level indicator values can be found here: </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en\">http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Method of estimation</p>\n      </td>\n      <td>\n        <p>The indicator is computed by averaging, across the 13 core capacities, the percentage of attributes for each capacity that have been attained.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>UHC-related notes</p>\n      </td>\n      <td>\n        <p>Countries began reporting IHR core capacity attainment to WHO for the year 2010. The earliest available IHR score for each country is used for all years 2000-2009.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>","es":"<p>Objetivo 3: Garantizar una vida sana y promover el bienestar de todos a todas las edades</p><p>Meta 3.8: Lograr la cobertura sanitaria universal, incluida la protección contra los riesgos financieros, el acceso a servicios de salud esenciales de calidad y el acceso a medicamentos y vacunas inocuos, eficaces, asequibles y de calidad para todos</p><p>Indicador 3.8.1: Cobertura de los servicios de salud esenciales</p><p> Última actualización: marzo de 2020 </p><h1>Indicadores relacionados en febrero de 2020</h1>\n<p>El índice de cobertura de servicios de la Cobertura Sanitaria Universal (CSU) está diseñado para resumir los indicadores existentes de la cobertura de los servicios de salud con el fin de garantizar la coherencia con los ODS y otras iniciativas mundiales y reducir la duplicación y la carga de información. Actualmente, el índice incluye otros dos indicadores de los ODS (3.a.1 y 3.d.1).</p>\n<p>El indicador 3.8.1 debe interpretarse siempre junto con el otro indicador de ODS sobre la cobertura sanitaria universal, el 3.8.2, que mide la protección financiera.</p><h1>Información institucional </h1>\n<h2>Organización (es): </h2>\n<p>Organización Mundial de la Salud (OMS) </p><h1>Conceptos y definiciones</h1>\n<h2>Definición:</h2>\n<p>Cobertura de los servicios sanitarios esenciales (definida como la cobertura media de los servicios esenciales basada en intervenciones de seguimiento que incluyen la salud reproductiva, materna, neonatal e infantil, las enfermedades infecciosas, las enfermedades no transmisibles y la capacidad y el acceso a los servicios, entre la población general y la más desfavorecida).</p>\n<p>El indicador es un índice reportado en una escala sin unidades de 0 a 100, que se calcula como la media geométrica de 14 indicadores trazadores de la cobertura de los servicios de salud.</p>\n<h2>Conceptos:</h2>\n<p>El índice de cobertura de servicios sanitarios se calcula como la media geométrica de 14 indicadores trazadores. Los 14 indicadores se enumeran a continuación y los metadatos detallados de cada uno de los componentes se ofrecen en línea (<a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf\">http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf</a>) y en el anexo 1. Los indicadores de seguimiento son los siguientes, organizados por cuatro grandes categorías de cobertura de servicios:</p>\n<p><strong><em>I. Salud reproductiva, materna, neonatal e infantil</em></strong>.</p>\n<p>1. <strong>Planificación familiar</strong>: Porcentaje de mujeres en edad reproductiva (15&#x2212;49 años) casadas o unidas que satisfacen su necesidad de planificación familiar con métodos modernos.</p>\n<p>2. <strong>Atención al embarazo y al parto</strong>: Porcentaje de mujeres de 15 a 49 años con un nacimiento vivo en un período de tiempo determinado que recibieron atención prenatal cuatro o más veces.</p>\n<p>3. <strong>Inmunización infantil</strong>: Porcentaje de lactantes que recibieron tres dosis de la vacuna que contiene difteria-tétanos-tos ferina.</p>\n<p>4. <strong>Tratamiento infantil</strong>: Porcentaje de niños menores de 5 años con sospecha de neumonía (tos y dificultad para respirar NO debidas a un problema en el pecho y a una nariz obstruida) en las dos semanas anteriores a la encuesta llevados a un centro o proveedor de salud apropiado.</p>\n<p><strong><em>II. Enfermedades infecciosas</em></strong>.</p>\n<p>5. <strong>Tuberculosis</strong>: Porcentaje de casos incidentes de tuberculosis detectados y tratados con éxito.</p>\n<p>6. <strong>VIH/SIDA</strong>: Porcentaje de personas que viven con el VIH que reciben actualmente terapia antirretroviral.</p>\n<p>7. <strong>Malaria</strong>: Porcentaje de la población en zonas donde la malaria es endémica que durmió bajo un mosquitero tratado con insecticida la noche anterior [sólo para países con alta carga de malaria].</p>\n<p>8. <strong>Agua y saneamiento</strong>: Porcentaje de hogares que utilizan al menos instalaciones de saneamiento básicas.</p>\n<p><strong><em>III. Enfermedades No Transmisibles</em></strong>.</p>\n<p>9. <strong>Hipertensión</strong>: Prevalencia estandarizada por edad de la presión arterial no elevada (presión arterial sistólica &lt;140 mm Hg o presión arterial diastólica &lt;90 mm Hg) entre los adultos de 18 años o más.</p>\n<p>10. <strong>Diabetes</strong>: Media de glucosa plasmática en ayunas estandarizada por edad (mmol/L) para adultos de 18 años o más.</p>\n<p>11. <strong>Tabaco</strong>: Prevalencia estandarizada por edad de adultos &gt;=15 años que no han fumado tabaco en los últimos 30 días (indicador 3.a.1 de los ODS, metadatos disponibles <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0a-01.pdf\">aquí</a>).</p>\n<p><strong><em>IV. Capacidad de servicio y acceso</em></strong>.</p>\n<p>12. <strong>Acceso a hospitales</strong>: Camas de hospital per cápita, en relación con un umbral máximo de 18 por cada 10.000 habitantes.</p>\n<p>13. <strong>Personal sanitario</strong>: Profesionales de la salud (médicos, psiquiatras y cirujanos) per cápita, en relación con los umbrales máximos para cada cuadro (solapamiento parcial con el indicador 3.c.1 de los ODS, ver metadatos <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0C-01.pdf\">aquí</a>).</p>\n<p>14. <strong>Seguridad sanitaria</strong>: Índice de capacidad básica del Reglamento Sanitario Internacional (RSI), que es el porcentaje medio de atributos de 13 capacidades básicas que se han alcanzado (indicador 3.d.1 de los ODS, véanse los metadatos <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0D-01.pdf\">aquí</a>).</p><h1>Fuentes de datos</h1>\n<h2>Descripción:</h2>\n<p>Muchos de los indicadores de seguimiento de la cobertura de los servicios sanitarios se miden mediante encuestas a hogares. Sin embargo, para algunos indicadores se utilizan datos administrativos, datos de los establecimientos, encuestas de los establecimientos y sistemas de monitoreo centinelas. Las fuentes de datos subyacentes para cada uno de los 14 indicadores trazadores se explican con más detalle en el Anexo 1.</p>\n<p>En cuanto a los valores utilizados para calcular el índice, los valores se toman de fuentes publicadas existentes. Esto incluye conjuntos de datos ensamblados y estimaciones de varias agencias de la ONU. Esto se resume en el enlace anterior.</p><h2>Proceso de recolección:</h2>\n<p>Los mecanismos de recolección de datos de los países varían en función de los 14 indicadores trazadores; sin embargo, en muchos casos, un organismo de las Naciones Unidas o un grupo interinstitucional ha reunido y analizado las fuentes de datos nacionales pertinentes y, a continuación, ha llevado a cabo una consulta formal con los gobiernos de los países para revisar o producir estimaciones nacionales comparables. Para el índice de cobertura de servicios de la CSU, una vez que se ha cotejado esta información existente sobre los 14 indicadores de seguimiento, la OMS lleva a cabo una consulta por país con los puntos focales designados por los gobiernos nacionales para revisar las aportaciones y el cálculo del índice. La OMS no lleva a cabo nuevas actividades de estimación para producir valores de indicadores trazadores para el índice de cobertura de servicios; más bien, el índice está diseñado para hacer uso de series de datos de indicadores existentes y bien establecidos para reducir la carga de notificación.</p><h1>Calendario</h1>\n<h2>Recopilación de datos:</h2>\n<p>La recopilación de datos varía de 1 a 5 años entre los indicadores de seguimiento. Por ejemplo, los datos de los países sobre inmunizaciones y tratamiento del VIH se comunican anualmente, mientras que las encuestas a hogares para recopilar información sobre el tratamiento de los niños pueden realizarse cada 3-5 años, dependiendo del país. En el Anexo 1 se pueden encontrar más detalles sobre los indicadores de seguimiento individuales.</p><h2>Publicación de datos:</h2>\n<p>La primera publicación de los valores de referencia para el índice de cobertura de servicios de CSU tuvo lugar en diciembre de 2017. Está previsto que se publique una actualización en septiembre de 2019.</p><h1>Proveedores de datos</h1>\n<p>En la mayoría de los casos, los Ministerios de Salud y las Oficinas Nacionales de Estadística supervisan la recopilación de datos y la presentación de informes para los indicadores de cobertura de los servicios sanitarios.</p><h1>Compiladores de datos</h1>\n<p>La Organización Mundial de la Salud, a partir de las aportaciones de otros organismos internacionales.</p><h2>Justificación:</h2>\n<p>La meta 3.8 se define como &#x201C;Lograr la cobertura sanitaria universal, incluida la protección contra los riesgos financieros, el acceso a servicios sanitarios esenciales de calidad y el acceso a medicamentos y vacunas esenciales seguros, eficaces, de calidad y asequibles para todos&#x201D;. Se trata que todas las personas y comunidades reciban los servicios sanitarios de calidad que necesitan (incluidos los medicamentos y otros productos sanitarios), sin que tengan que pasar apuros económicos. Se han elegido dos indicadores para supervisar la meta 3.8 en el marco de los ODS. El indicador 3.8.1 se refiere a la cobertura de los servicios sanitarios y el indicador 3.8.2 se centra en los gastos sanitarios en relación con el presupuesto de un hogar para identificar las dificultades financieras causadas por los pagos directos de la atención sanitaria. En conjunto, los indicadores 3.8.1 y 3.8.2 pretenden captar las dimensiones de cobertura de servicios y protección financiera, respectivamente, de la meta 3.8. Estos dos indicadores deberían ser siempre monitoreados conjuntamente.</p>\n<p>Los países proporcionan muchos servicios esenciales para la protección, promoción, prevención, tratamiento y atención sanitaria. Los indicadores de cobertura de servicios, definidos como las personas que reciben el servicio que necesitan, son la mejor manera de seguir el progreso en la prestación de servicios en el marco de la cobertura sanitaria universal (CSU). Dado que un único indicador de servicios sanitarios no es suficiente para el seguimiento de la CSU, se construye un índice a partir de 14 indicadores de seguimiento seleccionados en base a criterios epidemiológicos y estadísticos. Esto incluye varios indicadores que ya están incluidos en otras metas de los ODS, minimizando así la carga de recopilación de datos y la presentación de informes. El índice se presenta en una escala sin unidades de 0 a 100, siendo 100 el valor óptimo.</p><h2>Comentarios y limitaciones:</h2>\n<p>Estos indicadores trazadores pretenden ser indicativos de la cobertura de servicios, no una lista completa o exhaustiva de los servicios e intervenciones sanitarias que se requieren para la cobertura sanitaria universal. Los 14 indicadores trazadores se seleccionaron porque están bien establecidos, con datos disponibles ampliamente reportados por los países (o que se espera que estén ampliamente disponibles pronto). Por lo tanto, el índice puede calcularse con las fuentes de datos existentes y no requiere iniciar nuevos esfuerzos de recopilación de datos únicamente para informar el índice.</p><h1>Metodología</h1>\n<p><strong>Método de cálculo:</strong></p>\n<p>El índice se calcula con medias geométricas, basándose en los métodos utilizados para el Índice de Desarrollo Humano. El cálculo del indicador 3.8.1 requiere, en primer lugar, la preparación de los 14 indicadores trazadores para que puedan combinarse en el índice y, a continuación, el cálculo del índice a partir de esos valores.</p>\n<p>Los 14 indicadores trazadores se colocan primero en la misma escala, siendo 0 el valor más bajo y 100 el valor óptimo. Para la mayoría de los indicadores, esta escala es la escala natural de medición, por ejemplo, el porcentaje de bebés que han sido vacunados va de 0 a 100 por ciento. Sin embargo, para unos pocos indicadores se requiere un reajuste adicional para obtener valores apropiados de 0 a 100, como se indica a continuación:</p>\n<ul>\n  <li>Recalificación basada en un mínimo no nulo para obtener una resolución más fina (esto &#x201C;estira&#x201D; la distribución entre los países): la prevalencia de la presión arterial no elevada y la prevalencia del no consumo de tabaco se reescalan utilizando un valor mínimo del 50%.<ul>\n      <li>Valor reescalado = (X-50)/(100-50)*100</li>\n    </ul>\n  </li>\n  <li>Escalado para una medida continua: la glucosa plasmática media en ayunas, que es una medida continua (unidades de mmol/L), se convierte a una escala de 0 a 100 utilizando el riesgo biológico mínimo teórico (5,1 mmol/L) y el máximo observado en todos los países (7,1 mmol/L).<ul>\n      <li>Valor reescalado = (7,1 - valor original)/(7,1-5,1)*100</li>\n    </ul>\n    </li>\n  <li>Los umbrales máximos para los indicadores de la tasa: la densidad de camas hospitalarias y la densidad de personal sanitario se limitan a los umbrales máximos, y los valores por encima de este umbral se mantienen constantes en 100. Estos umbrales se basan en los valores mínimos observados en los países de la OCDE.<ul>\n      <li>camas hospitalarias reescaladas por cada 10.000 = mínimo (100, valor original / 18*100)</li>\n      <li>Médicos reescalados por cada 1.000 = mínimo (100, valor original / 0,9*100)</li> \n      <li>psiquiatras reescalados por cada 100.000 = mínimo (100, valor original / 1*100)</li>\n      <li>cirujanos reescalados por cada 100.000 = mínimo (100, valor original / 14*100)</li>\n    </ul>\n  </li>\n</ul>\n<p>Una vez que todos los valores de los indicadores trazadores están en una escala de 0 a 100, se calculan las medias geométricas dentro de cada una de las cuatro áreas de servicios de salud, y luego se toma una media geométrica de esos cuatro valores. Si el valor de un indicador trazador resulta ser cero, se fija en 1 (sobre 100) antes de calcular la media geométrica. El siguiente diagrama ilustra los cálculos.</p>\n<p><img src=\"data:image/png;base64,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\"></p>\n<p>Nótese que en los países con baja carga de paludismo, el indicador de seguimiento del uso de mosquiteros tratados con insecticida se elimina del cálculo.</p><h2>Tratamiento de valores faltantes:</h2>\n<ul>\n<li><strong><em>A nivel de país:</em></strong></li>\n</ul>\n<p>El punto de partida para calcular el índice es reunir la información existente para cada indicador de seguimiento. En muchos casos, esto implica el uso de series temporales de países que han sido producidas o cotejadas por organismos de las Naciones Unidas en consulta con los gobiernos de los países (por ejemplo, la cobertura de inmunización, el acceso al saneamiento, la cobertura del tratamiento del VIH, etc.). Algunas de estas series temporales publicadas implican la elaboración de modelos matemáticos para conciliar múltiples fuentes de datos o imputar los valores faltantes, y estos detalles se resumen en el Anexo 1.</p>\n<p>Después de ensamblar estos datos, todavía hay valores faltantes en algunos países/años para algunos indicadores. El cálculo del índice de cobertura de servicios de salud universal requiere valores para cada indicador de seguimiento de un país, por lo que es necesario realizar alguna imputación para cubrir estas brechas de datos. El enfoque actual consiste en un sencillo algoritmo de imputación. Para cada indicador:</p>\n<ul>\n  <li>\n    <ul>\n      <li> Si un país tiene valores faltantes entre dos años con valores, se utiliza la interpolación lineal para rellenar los valores faltantes de los años intermedios</li>\n      <li>Si un país tiene años históricos con valores, pero ningún valor actual, se utiliza la extrapolación constante para rellenar los valores faltantes hasta el año actual</li>\n      <li>Si un país no tiene valores, se imputa un valor. En el caso de la búsqueda de atención por neumonía y la densidad de cirujanos, se ajusta una regresión para imputar los valores faltantes (véase el anexo 1 para más detalles). Para todos los demás indicadores, se calcula una mediana regional para imputar los valores faltantes. Las regiones se basan en las regiones geográficas del Banco Mundial, con una agrupación separada de los países tradicionales de ingresos altos<sup><a href=\"#footnote-1\" id=\"footnote-ref-1\">[1]</a></sup></li>\n    </ul>\n  </li>\n</ul>\n<p>Debido al calendario y la distribución de las diversas encuestas de salud y otros mecanismos de recopilación de datos, los países no recopilan ni informan sobre los 14 indicadores de seguimiento de la cobertura de los servicios de salud con carácter anual. Además, el seguimiento a nivel de país se realiza más adecuadamente en intervalos de tiempo más amplios, por ejemplo, cada 5 años, para permitir la recopilación de nuevos datos en los indicadores. Por lo tanto, la medida en que se ha utilizado la imputación para completar la información faltante debe comunicarse junto con el valor del índice.</p>\n<ul>\n<li><strong><em>A nivel regional y mundial:</em></strong></li>\n</ul>\n<p>Cualquier imputación necesaria se realiza a nivel de país. Estos valores de los países pueden utilizarse para calcular los valores regionales y globales.</p><div class=\"footnotes\"><div><sup class=\"footnote-number\" id=\"footnote-1\">1</sup><p> Alemania, Argentina, Australia, Austria, Bélgica, Brunei Darussalam, Canadá, Chile, Chipre, Chequia, Dinamarca, Estonia, Finlandia, Francia, Grecia, Irlanda, Islandia, Israel, Italia, Japón, Luxemburgo, Malta, Países Bajos, Nueva Zelanda, Noruega, Polonia, Portugal, República de Corea, Singapur, Eslovaquia, Eslovenia, España, Suecia, Suiza, Reino Unido, Estados Unidos de América, Uruguay <a href=\"#footnote-ref-1\">&#x2191;</a></p></div></div><h2>Agregados regionales:</h2>\n<p>Los agregados regionales y mundiales se calculan utilizando los tamaños de la población nacional para calcular una media ponderada de los valores específicos de cada país para el índice. Esto se justifica por el hecho de que la CSU es una propiedad de los países, y el índice de servicios esenciales es una medida resumida del acceso a los servicios esenciales para la población de cada país.</p><h1> Disponibilidad de los datos</h1>\n<h2> Descripción:</h2>\n<p>Resumir la disponibilidad de datos para el índice de cobertura del servicio CSU no es sencillo, ya que se utilizan diferentes fuentes de datos en los 14 indicadores de seguimiento. Además, para muchos indicadores se han producido estimaciones comparables, en muchos casos recurriendo a diferentes tipos de fuentes de datos subyacentes para informar las estimaciones y al mismo tiempo utilizar proyecciones para imputar los valores faltantes. Sobre la base de las fuentes de datos subyacentes para cada uno de los indicadores de seguimiento (es decir, ignorando las estimaciones y proyecciones), la proporción promedio de indicadores utilizados para calcular el índice con los datos subyacentes disponibles desde 2010 es de alrededor del 70% en todos los países del mundo.</p>\n<h2>Serie temporal:</h2>\n<p>A finales de 2017 se publicó un valor de referencia para el índice de cobertura de los servicios de CSU para 2015 en 183 países. Como parte de este proceso, se reunieron fuentes de datos que se remontan a 2000. En 2019, se prevé publicar una serie temporal de 2000 a 2017.</p>\n<h2>Desagregación:</h2>\n<p>La equidad es fundamental para la definición de la CSU y, por lo tanto, el índice de cobertura de los servicios de CSU debe utilizarse para comunicar información sobre las desigualdades en la cobertura de los servicios dentro de los países. Esto se puede hacer presentando el índice por separado para la población nacional frente a las poblaciones desfavorecidas para resaltar las diferencias entre ellas.</p>\n<p>Para los países, la ubicación geográfica es probablemente la dimensión más factible para la desagregación sub-nacional basada en los niveles medios de cobertura medidos con las fuentes de datos existentes. Para ello, el índice de CSU puede calcularse por separado, por ejemplo, por la provincia o la residencia urbana frente a la rural, lo que permitiría realizar comparaciones sub-nacionales de la cobertura de los servicios. En la actualidad, los datos más fácilmente disponibles para desagregar otras dimensiones de la desigualdad, como la riqueza de los hogares, se refieren a los indicadores de cobertura dentro de la categoría de servicios de salud reproductiva, materna, neonatal e infantil. La desigualdad observada en esta dimensión se puede utilizar como un proxy para comprender las diferencias en la cobertura de servicios entre las dimensiones clave de desigualdad. Este enfoque debería sustituirse por la desagregación completa de los 14 indicadores de trazado una vez que se disponga de datos para hacerlo.</p><h2>Fuentes de discrepancias:</h2>\n<p>El índice de cobertura de servicios se basa en datos y estimaciones existentes y disponibles públicamente para los indicadores de seguimiento. Estas cifras ya han pasado por un proceso de consulta con el país (por ejemplo, para la cobertura de inmunización), o se toman directamente de los datos notificados por el país.</p><h1>Referencias</h1>\n<h2><strong>URL: </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<h2><strong>Referencias: </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/</a></p>\n<p><a href=\"http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf\">http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<p>Para la evolución histórica de los métodos, véase:</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1\">http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1</a> (sustituido por este documento)</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/</a></p>\n<p><a href=\"http://collections.plos.org/uhc2014\">http://collections.plos.org/uhc2014</a></p>\n<h1>Anexo 1: Metadatos de los indicadores trazadores utilizados para medir la cobertura de los servicios sanitarios esenciales para el seguimiento del indicador 3.8.1 de los ODS.</h1>\n<p>Por favor, envíe cualquier comentario o consulta a: <a href=\"mailto:uhc_stats@who.int\">uhc_stats@who.int</a></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Planificación familiar</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de mujeres en edad reproductiva (15&#x2212;49 años) casadas o en unión libre que tienen su necesidad de planificación familiar satisfecha con métodos modernos</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de mujeres de 15 a 49 años casadas o unidas que utilizan métodos modernos</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número total de mujeres de 15 a 49 años casadas o unidas que necesitan planificación familiar</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Encuestas de salud basadas en la población</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Las encuestas de hogares incluyen una serie de preguntas para medir la tasa de prevalencia de anticonceptivos modernos y la demanda de planificación familiar. La demanda total de planificación familiar se define como la suma del número de mujeres en edad reproductiva (15&#x2013;49 años) que están casadas o en pareja y que actualmente utilizan, o cuya pareja sexual utiliza actualmente, al menos un método anticonceptivo, y la necesidad insatisfecha de planificación familiar. La necesidad insatisfecha de planificación familiar es la proporción de mujeres en edad reproductiva (15&#x2013;49 años) casadas o en una unión consensuada, que son fecundas y sexualmente activas pero que no utilizan ningún método anticonceptivo (moderno o tradicional), y que declaran no querer tener más hijos o querer retrasar el nacimiento de su siguiente hijo durante al menos dos años. Se incluyen:</p>\n        <p>todas las mujeres embarazadas (casadas o en una unión consensuada) cuyos embarazos fueron no deseados o inoportunos en el momento de la concepción;</p>\n        <p>todas las mujeres amenorreicas posparto (casadas o en unión consensuada) que no utilizan planificación familiar y cuyo último parto fue no deseado o inoportuno;</p>\n        <p>Todas las mujeres fecundas (casadas o en unión consensuada) que no están embarazadas ni son amenorreicas posparto, y que o bien no quieren tener más hijos (quieren limitar el tamaño de la familia), o bien desean posponer el nacimiento de un hijo durante al menos dos años o no saben cuándo o si quieren tener otro hijo (quieren espaciar los nacimientos), pero no están utilizando ningún método anticonceptivo.</p>\n        <p>Los métodos modernos incluyen la esterilización femenina y masculina, el dispositivo intrauterino (DIU), el implante, los inyectables, las píldoras anticonceptivas orales, los preservativos masculinos y femeninos, los métodos vaginales de barrera (incluidos el diafragma, el capuchón cervical y la espuma, la jalea, la crema y la esponja espermicida), el método de amenorrea de la lactancia (LAM, por su sigla en inglés), la anticoncepción de emergencia y otros métodos modernos no informados por separado.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>La División de Población de las Naciones Unidas produce una serie sistemática y completa de estimaciones y proyecciones anuales del porcentaje de demanda de planificación familiar que se satisface entre las mujeres casadas o unidas. Se utiliza un modelo jerárquico bayesiano combinado con datos específicos de cada país para generar las estimaciones, proyecciones y evaluaciones de incertidumbre a partir de los datos de las encuestas. El modelo tiene en cuenta las diferencias según la fuente de datos, la población de la muestra y los métodos anticonceptivos.</p>\n        <p>Vea aquí los detalles: <a href=\"http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml\">http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n     </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Atención al embarazo y al parto</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de mujeres de entre 15 y 49 años con un nacimiento vivo en un periodo de tiempo determinado que recibieron atención prenatal cuatro o más veces</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de mujeres de 15&#x2212;49 años con un nacimiento vivo en un período de tiempo determinado que recibieron atención prenatal cuatro o más veces</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número total de mujeres de 15&#x2212;49 años con un nacimiento vivo en el mismo período</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Encuestas a hogares y sistemas de información rutinarios de los establecimientos</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Los datos sobre cuatro o más visitas de atención prenatal se basan en preguntas que consultan si se controló la salud de la mujer durante el embarazo y cuántas veces. Las encuestas a hogares que pueden generar este indicador incluyen DHS, MICS, RHS (por sus siglas en inglés) y otras encuestas basadas en metodologías similares. Los sistemas de notificación de servicios/centros pueden utilizarse cuando la cobertura es alta, normalmente en los países de ingresos más altos.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>La OMS mantiene una base de datos sobre la cobertura de la atención prenatal: <a href=\"http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4\">http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>En principio, este indicador se sustituiría por una medida más exhaustiva de la atención al embarazo y al parto, por ejemplo, la proporción de mujeres que tienen un proveedor cualificado que asiste al parto o un parto institucional. Un reto a la hora de medir la asistencia cualificada al parto es determinar qué proveedores son &#x201C;calificados&#x201D;.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<p><br></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Inmunización infantil</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de lactantes que reciben tres dosis de la vacuna que contiene difteria-tétanos-tos ferina.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Niños de 1 año de edad que han recibido tres dosis de la vacuna que contiene difteria-tétanos-tos ferina.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Todos los niños de 1 año de edad.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos.</p>\n      </td>\n      <td>\n        <p>Encuestas a hogares y sistemas de información de instalaciones.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición.</p>\n      </td>\n      <td>\n        <p>Para los datos de la encuesta, el estado de vacunación de los niños de 12&#x2013;23 meses se recopila de las tarjetas de salud infantil o, si no hay tarjeta, del recuerdo del cuidador. Para los datos administrativos, se extrae el número total de dosis administradas a la población objetivo.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Juntos, la OMS y el UNICEF obtienen estimaciones de la cobertura de la DTP3 basadas en los datos comunicados oficialmente a la OMS y al UNICEF por los Estados Miembros, así como en los datos comunicados en la literatura publicada y gris. También consultan a expertos locales -principalmente a los gestores nacionales del PAI y al personal de las oficinas regionales de la OMS- para obtener información adicional sobre el funcionamiento de servicios de inmunización locales específicos. Sobre la base de los datos disponibles, la consideración de posibles sesgos y las contribuciones de los expertos locales, la OMS y el UNICEF determinan el nivel real más probable de cobertura de inmunización </p>\n        <p>Para más detalles, véase aquí:</p>\n        <p><a href=\"http://www.who.int/bulletin/volumes/87/7/08-053819/en/\">http://www.who.int/bulletin/volumes/87/7/08-053819/en/</a></p>\n        <p><a href=\"http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html\">http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>Existe una variabilidad en los calendarios nacionales de vacunación entre los países. Teniendo en cuenta esto, una opción para supervisar la inmunización completa de los niños es supervisar la fracción de niños que reciben las vacunas incluidas en el calendario nacional de su país. Una segunda opción, que puede ser más comparable entre países y en el tiempo, es vigilar la cobertura de la DTP3 como indicador de la inmunización infantil completa. La vacuna que contiene difteria-tétanos-tos ferina suele incluir otras vacunas, por ejemplo, contra la hepatitis B y el Haemophilus influenza tipo B, y es una medida razonable del grado de solidez de la plataforma de vacunación de un país.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Tratamiento de niños (búsqueda de atención por síntomas de neumonía).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de niños menores de 5 años con sospecha de neumonía (tos y dificultad para respirar NO debidas a un problema en el pecho y a una nariz tapada) en las dos semanas anteriores a la encuesta llevados a un centro o proveedor de salud adecuado.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>.\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de niños con sospecha de neumonía en las dos semanas anteriores a la encuesta llevados a un proveedor de salud adecuado.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número de niños con sospecha de neumonía en las dos semanas anteriores a la encuesta.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Encuestas de hogares.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Durante la Reunión de UNICEF/OMS sobre indicadores basados en encuestas de supervivencia infantil, celebrada en Nueva York el 17&#x2013;18 de junio de 2004, se recomendó que las infecciones respiratorias agudas (IRA) se describieran como &#x201C;presunta neumonía&#x201D; para reflejar mejor la causa probable y las intervenciones recomendadas. La definición de presunta neumonía utilizada en las Encuestas Demográficas y de Salud (EDS) y en las Encuestas de Indicadores Múltiples por Conglomerados (MICS, por su sigla en inglés) fue elegida por el grupo y se basa en la percepción de las madres de que un niño tiene tos, respira más rápido de lo habitual con respiraciones cortas y rápidas o tiene dificultades para respirar, excluyendo a los niños que sólo tenían la nariz tapada. La definición de \"proveedor de atención adecuada\" varía según los países.</p>\n        <p>La OMS mantiene una base de datos de observaciones a nivel de país de las encuestas de hogares a la que se puede acceder aquí: <a href=\"http://apps.who.int/gho/data/node.main.38?lang=en\">http://apps.who.int/gho/data/node.main.38?lang=en</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Actualmente no existen estimaciones comparables a nivel internacional para este indicador.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>Este indicador no suele medirse en los países de mayor renta con sistemas sanitarios bien establecidos.</p>\n        <p>Para los países sin datos observados, la cobertura se estimó a partir de una regresión que predice la cobertura de la búsqueda de atención para los síntomas de la neumonía (en la escala logit), obtenida de la base de datos de la OMS descrita anteriormente, en función del logaritmo de la tasa estimada de mortalidad por neumonía en menores de cinco años, que se puede encontrar aquí: <a href=\"https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html\">https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html</a>.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Tratamiento de la tuberculosis.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de casos de incidencia de tuberculosis que se detectan y tratan con éxito en un año determinado.</p>\n      </td>\n    </tr>\n    <tr>.\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de casos nuevos y de recaída detectados en un año determinado y tratados con éxito.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número de casos nuevos y de recaídas en el mismo año.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Sistemas de información de los centros, sistemas de vigilancia, encuestas de salud basadas en la población con pruebas de diagnóstico de la tuberculosis, registro de la tuberculosis y sistema de notificación trimestral relacionado (o registros electrónicos de la tuberculosis)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Este indicador requiere tres insumos principales:</p>\n        <p>(1) El número de casos de tuberculosis nuevos y de recaída diagnosticados y tratados en los programas nacionales de control de la tuberculosis y notificados a la OMS en un año determinado.</p>\n        <p>(2) El número de casos incidentes de TB para el mismo año, normalmente estimado por la OMS.</p>\n        <p>(3) Porcentaje de casos de tuberculosis tratados con éxito (curados más tratamiento completado) entre los casos de tuberculosis notificados a las autoridades sanitarias nacionales.</p>\n        <p>El indicador final = (1)/(2) x (3).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Las estimaciones de la incidencia de la tuberculosis se elaboran mediante un proceso consultivo y analítico dirigido por la OMS y se publican anualmente. Estas estimaciones se basan en las notificaciones anuales de casos, las evaluaciones de la calidad y la cobertura de los datos de notificación de la tuberculosis, las encuestas nacionales de prevalencia de la enfermedad de la tuberculosis y la información de los sistemas de registro de defunciones (vitales). Las estimaciones de incidencia para cada país se derivan, utilizando uno o más de los siguientes enfoques, dependiendo de los datos disponibles:</p>\n        <p>1. incidencia = notificaciones de casos/proporción estimada de casos detectados;</p>\n        <p>2. incidencia = prevalencia/duración de la enfermedad;</p>\n        <p>3. incidencia = muertes/proporción de casos incidentes que fallecen.</p>\n        <p>Estas estimaciones de la incidencia de la tuberculosis se combinan con los datos notificados por los países sobre el número de casos detectados y tratados, y el porcentaje de casos tratados con éxito, como se ha descrito anteriormente.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>Para calcular el indicador utilizando las estimaciones de la OMS, se puede acceder a los archivos necesarios aquí: <a href=\"http://www.who.int/tb/country/data/download/en/\">http://www.who.int/tb/country/data/download/en/</a>, y calcular el indicador como = c_cdr x c_new_tsr.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Tratamiento del VIH.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de personas que viven con el VIH y que actualmente reciben terapia antirretroviral (ART).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>.\n        <p>Número de adultos y niños que están recibiendo actualmente tratamiento antirretroviral al final del período de notificación.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número de adultos y niños que viven con el VIH durante el mismo periodo.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Sistemas de notificación de los centros, sitios de vigilancia centinela, encuestas basadas en la población.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Numerador: El numerador puede generarse contando el número de adultos y niños que recibieron terapia combinada antirretroviral al final del periodo de notificación. Los datos pueden recopilarse a partir de los registros de tratamiento antirretroviral de los centros o de los sistemas de gestión de suministros de medicamentos. A continuación, se contabilizan y se transfieren a informes transversales mensuales o trimestrales que pueden agregarse a los totales nacionales. Los pacientes que reciben terapia antirretroviral en el sector privado y en el sector público deben incluirse en el numerador.</p>\n        <p>Denominador: Los datos sobre el número de personas infectadas por el VIH pueden proceder de encuestas de población o, como es habitual en el África subsahariana, de sistemas de vigilancia basados en las clínicas de atención prenatal.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Las estimaciones de la cobertura del tratamiento antirretroviral entre las personas que viven con el VIH para el período 2000-2018 se derivan como parte de la ronda de estimación de ONUSIDA de 2019.</p>\n        <p>Para estimar el número de personas que viven con el VIH a lo largo del tiempo en los países con alta carga, ONU/SIDA, en colaboración con los países, utiliza un modelo epidémico (Spectrum) que combina los datos de vigilancia sobre la prevalencia con el número actual de pacientes que reciben tratamiento antirretroviral y las hipótesis sobre la historia natural de la progresión de la enfermedad del VIH.</p>\n        <p>Dado que la terapia antirretrovírica se recomienda ahora a todas las personas que viven con el VIH, el seguimiento de la cobertura de la terapia antirretrovírica es menos complicado que antes, cuando sólo podían recibirla las personas con un determinado nivel de gravedad de la enfermedad.</p>\n        <p>Las estimaciones de la cobertura del TAR se pueden encontrar aquí: http://aidsinfo.unaids.org/.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>No siempre se dispone de estimaciones comparables de la cobertura de la terapia antirretroviral en los países de renta alta, en particular de las tendencias temporales.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Prevención de la malaria.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de la población de las zonas donde la malaria es endémica que durmió con un mosquitero impregnado de insecticida la noche anterior.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de personas en zonas donde la malaria es endémica que durmieron bajo un MTI.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número total de personas en zonas donde la malaria es endémica.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Los datos sobre el acceso y el uso de los mosquiteros por parte de los hogares provienen de encuestas a hogares representativas a nivel nacional, como las Encuestas Demográficas y de Salud, las Encuestas de Indicadores Múltiples por Conglomerados y las Encuestas de Indicadores de Malaria. Los datos sobre el número de MTI entregados por los fabricantes a los países son recopilados por Milliner Global Associates, y los datos sobre el número de MTI distribuidos dentro de los países son comunicados por los Programas Nacionales de Control de la Malaria.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Muchas encuestas nacionales recientes informan del número de MTI observados en cada hogar encuestado. Las tasas de propiedad pueden convertirse en la proporción de personas que duermen bajo un MTI utilizando una relación lineal entre el acceso y el uso que se ha derivado de 62 encuestas que recopilan información sobre ambos indicadores.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Se pueden utilizar modelos matemáticos para combinar los datos de las encuestas a hogares sobre el acceso y el uso con la información sobre la entrega de MTI por parte de los fabricantes y la distribución de MTI por parte de los programas nacionales de malaria para producir estimaciones anuales de la cobertura de MTI. La OMS utiliza este enfoque en colaboración con el Proyecto Atlas del Paludismo. Los detalles metodológicos se encuentran en el Anexo del Informe Mundial sobre el Paludismo 2015: <a href=\"http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/\">http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>La OMS elabora estimaciones comparables de la cobertura de los MTI para 40 países con alta carga. Para otros países, la cobertura de los mosquiteros no se incluye en el índice de cobertura de servicios de CSU debido a las limitaciones de los datos.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Agua y saneamiento.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Porcentaje de hogares que utilizan al menos instalaciones de saneamiento básico.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Población que vive en un hogar con: cisterna o vaciado al sistema de alcantarillado por tuberías, fosa séptica o letrina de pozo; letrina de pozo mejorada y ventilada; letrina de pozo con losa; o inodoro de compostaje.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Población total.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Encuestas a hogares y censos basados en la población.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Las respuestas a nivel de hogar, ponderadas por el tamaño del mismo, se utilizan para calcular la cobertura de la población.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>El Programa Conjunto de Monitoreo de la OMS y el UNICEF ha elaborado estimaciones periódicas de la cobertura de al menos el saneamiento básico para el monitoreo de los ODM. Después de compilar una base de datos de fuentes de datos disponibles, para cada país, se ajustan regresiones lineales simples a las series de datos del país para obtener una estimación dentro de la muestra, así como para producir una extrapolación de 2 años más allá del último punto de datos disponible, después de lo cual la cobertura se mantiene constante durante 4 años y luego se asume que falta. Esto se hace por separado para las regiones urbanas y rurales, y luego se combina para obtener estimaciones de cobertura nacional. Los detalles de la metodología y las estimaciones más recientes pueden encontrarse aquí: http://www.wssinfo.org/.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>El indicador de los ODS para el saneamiento (ODS 6.2.1) es una versión ampliada del indicador de los ODM, que incorpora la calidad de las instalaciones de saneamiento. No se utiliza para el seguimiento de la cobertura sanitaria universal debido a la menor disponibilidad de datos. También podría considerarse un indicador conjunto que identifique la proporción de hogares con acceso tanto a agua potable como a saneamiento.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Prevención de enfermedades cardiovasculares.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Prevalencia estandarizada por edad de presión arterial normal entre los adultos mayores de 18 años, independientemente del estado de tratamiento.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de adultos de 18 años o más con presión arterial sistólica &lt;140 mm Hg y presión arterial diastólica &lt;90 mm Hg (independientemente del estado del tratamiento).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número de adultos de 18 años o más.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Estudios basados en la población y sistemas de vigilancia.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n     </td>\n      <td>\n        <p>Se utilizan las fuentes de datos que registran la presión arterial medida (se excluyen los datos autodeclarados).&#xA0;Si se toman varias lecturas de presión arterial por participante, se descarta la primera lectura y se promedian las restantes.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Para producir estimaciones nacionales comparables, las observaciones de datos de prevalencia definidas en términos de cortes alternativos de PAS y/o PAD se convierten en prevalencia de presión arterial elevada, definida como presión arterial sistólica &gt;=140 mm Hg o presión arterial diastólica &gt;=90 mm Hg utilizando ecuaciones de regresión. A continuación, se ajusta un modelo jerárquico bayesiano a estos datos para calcular las prevalencias específicas por edad, sexo y país, que tiene en cuenta las fuentes de datos nacionales frente a las sub-nacionales, las fuentes de datos urbanas frente a las rurales, y permite la variación de la prevalencia según la edad y el sexo. Las estimaciones estandarizadas por edad se obtienen aplicando las estimaciones brutas a la población estándar de la OMS. Los detalles de los métodos estadísticos se encuentran aquí: <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext</a>.</p>\n        <p>La OMS y la NCD Risk Factor Collaboration (NCD-RisC, por su sigla en inglés) han elaborado estimaciones comparables para este indicador hasta el año 2015, que están disponibles aquí. </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en\">http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>Las estimaciones de prevalencia se convierten en la prevalencia de la presión arterial normal para su incorporación al índice CSU, de modo que un valor del 100% es el objetivo óptimo. Esto se calcula como: prevalencia de presión arterial normal = 1 &#x2013; prevalencia de presión arterial elevada. Las estimaciones anteriores se realizan por separado para hombres y mujeres; para el indicador de seguimiento de la CSU se calcula una media simple de los valores de hombres y mujeres.</p>\n        <p>La presión arterial normal es la suma del porcentaje de individuos que no tienen hipertensión y el porcentaje de individuos cuya hipertensión está controlada por la medicación. La ausencia de hipertensión es el resultado de los esfuerzos de prevención a través de la promoción de la actividad física y las dietas saludables, así como de otros factores. La hipertensión controlada con medicación es el resultado de un tratamiento eficaz. Este indicador es, por tanto, un indicador indirecto tanto de la promoción de la salud como de los servicios médicos eficaces.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Manejo de la diabetes</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Glucosa plasmática media en ayunas estandarizada por edad para adultos de 18 años o más.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Fuentes de datos principales</p>\n      </td>\n      <td>\n        <p>Estudios basados en la población y sistemas de vigilancia.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Los niveles de glucosa plasmática en ayunas (FPG, según su sigla en inglés) se determinan tomando una muestra de sangre de los participantes que han ayunado durante al menos 8 horas. Se utilizaron otros biomarcadores relacionados, como la hemoglobina A1c (HbA1c), para ayudar a calcular las estimaciones (véase más adelante).<p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Para producir estimaciones nacionales comparables, las observaciones de datos basadas en la FPG media, la prueba de tolerancia a la glucosa oral (OGTT, según su sigla en inglés), la HbA1c, o sus combinaciones, se convierten todas en FPG media. A continuación, se ajusta un modelo jerárquico bayesiano a estos datos para calcular las prevalencias específicas por edad, sexo y país, que tiene en cuenta las fuentes de datos nacionales frente a las sub-nacionales, las fuentes de datos urbanas frente a las rurales, y permite la variación de la prevalencia según la edad y el sexo. Las estimaciones estandarizadas por edad se obtienen aplicando las estimaciones brutas a la población estándar de la OMS. Los detalles metodológicos se pueden encontrar aquí: <a href=\"https://www.who.int/diabetes/global-report/en/\">https://www.who.int/diabetes/global-report/en/</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>La FPG de un individuo puede ser baja debido a un tratamiento eficaz con medicación reductora de la glucosa, o porque el individuo no es diabético como resultado de actividades de promoción de la salud u otros factores como la genética. La FPG media es, por tanto, un indicador de la promoción efectiva de dietas y comportamientos saludables y del tratamiento efectivo de la diabetes.</p>\n        <p>Las estimaciones anteriores se realizan por separado para hombres y mujeres; para el indicador de seguimiento de la CSU se calcula una media simple de los valores para hombres y mujeres.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Control del tabaco.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Prevalencia estandarizada por edad de adultos &gt;=15 años que no han fumado tabaco en los últimos 30 días.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Adultos de 15 años o más que no han fumado tabaco en los últimos 30 días.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Adultos de 15 años o más.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Encuestas a hogares.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>&#x201C;El consumo actual de tabaco&quot; incluye cigarrillos, puros, pipas o cualquier otro producto de tabaco fumado consumido en los últimos 30 días. Los datos se recopilan mediante autoinforme en las encuestas.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>La OMS estima la prevalencia del tabaquismo actual (no) con un modelo de metarregresión binomial negativa, que genera estimaciones comparables ajustando las diferencias en los grupos de edad y la definición de los indicadores entre las encuestas nacionales incluidas en el análisis. Estas estimaciones se realizan por separado para hombres y mujeres. Los detalles metodológicos se pueden encontrar aquí: <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>La prevalencia de no fumar tabaco se calcula como 1 menos la prevalencia de fumar tabaco.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Acceso al hospital.</p>\n      </td>\n    </tr>\n    <tr>.\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Camas hospitalarias per cápita, en relación con un umbral máximo de 18 por cada 10.000 habitantes.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de camas de hospital (debe excluir las camas de parto).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>.\n        <p>Población total.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Sistemas administrativos / Sistema de notificación de los centros de salud.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Se utilizan los sistemas administrativos de los países para totalizar el número de camas de hospital, que se dividen por la población total estimada, y se multiplican por 10.000.</p>\n        <p>Las oficinas regionales de la OMS y otros grupos recopilan información sobre la densidad nacional de camas hospitalarias, incluyendo los siguientes recursos en línea:</p>\n        <p><a href=\"https://rho.emro.who.int/rhodata/node.main.A36\">https://rho.emro.who.int/rhodata/node.main.A36</a>.</p>\n        <p>Observatorio regional AFRO de la OMS: <a href=\"http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population\">http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population</a></p>\n        <p>Base de datos europea de salud para todos EURO de la OMS: <a href=\"https://gateway.euro.who.int/en/datasets%20european-health-for-all-database/\">https://gateway.euro.who.int/en/datasets european-health-for-all-database/</a>.</p>\n        <p>OCDE: <a href=\"https://data.oecd.org/healtheqt/hospital-beds.htm\">https://data.oecd.org/healtheqt/hospital-beds.htm</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Utilizando los datos disponibles, el indicador se calcula en relación con un valor umbral de 18 camas de hospital por cada 10.000 habitantes. Este umbral está por debajo del mínimo observado en los países de renta alta de la OCDE (desde el año 2000) de 20 por 10.000 y suele corresponder a una tasa de ingresos hospitalarios de alrededor de 5 por 100 al año. Este indicador está diseñado para captar niveles bajos de capacidad hospitalaria; el umbral máximo se utiliza porque las densidades de camas hospitalarias muy altas no son necesariamente un uso eficiente de los recursos. El indicador se calcula de la siguiente manera, utilizando los datos del país sobre la densidad de camas hospitalarias (<em>x</em>), lo que da como resultado valores que van de 0 a 100:</p>\n        <p>País con una densidad de camas hospitalarias <em>x</em> &lt; 18 por 10.000 al año, el indicador = </p>\n        <p><em>x</em> /18*100.</p>\n        <p>País con una densidad de camas hospitalarias <em>x</em> &gt;= 18 por 10.000 al año, el indicador = 100.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>Un indicador alternativo podría ser la tasa de ingresos hospitalarios, en relación con un umbral máximo. Sin embargo, ese indicador no se comunica actualmente de forma generalizada en todas las regiones, en particular en la Región de África. En los países en los que se dispone tanto de camas de hospital per cápita como de tasas de admisión de pacientes internos, están muy correlacionados.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Personal sanitario.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Profesionales de la salud (médicos, psiquiatras y cirujanos) per cápita, en relación con los umbrales máximos de cada cuadro.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de médicos, psiquiatras y cirujanos.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Población total.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Base de datos o registro nacional de personal sanitario, idealmente acoplado a una evaluación periódica de la exhaustividad mediante datos censales, registros de asociaciones profesionales o censos de centros.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>La clasificación de los trabajadores sanitarios se basa en criterios de formación profesional, regulación de las profesiones sanitarias y actividades y tareas de los puestos de trabajo, es decir, en un marco de categorización de las variables clave de la fuerza de trabajo según características compartidas. El marco de la OMS se basa en gran medida en las últimas revisiones de los sistemas de clasificación normalizados internacionalmente de la Organización Internacional del Trabajo (Clasificación Internacional Uniforme de Ocupaciones), la Organización de las Naciones Unidas para la Educación, la Ciencia y la Cultura (Clasificación Internacional Uniforme de la Enseñanza) y la División de Estadísticas de las Naciones Unidas (Clasificación Industrial Internacional Uniforme de Todas las Actividades Económicas). </p>\n        <p>Los detalles metodológicos y los datos pueden encontrarse aquí: <a href=\"http://www.who.int/hrh/statistics/hwfstats/en/\">http://www.who.int/hrh/statistics/hwfstats/en/</a>.</p>\n        <p>Los datos proceden de las siguientes fuentes:</p>\n        <p>Médicos: <a href=\"http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en\">http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en</a>.</p>\n        <p>Psiquiatras: <a href=\"https://www.who.int/healthinfo/universal_health_coverage/report/2017/en/\">https://www.who.int/healthinfo/universal_health_coverage/report/2017/en/</a>.</p>\n        <p>Cirujanos: <a href=\"http://apps.who.int/gho/data/node.main.HWF9?lang=en%20\">http://apps.who.int/gho/data/node.main.HWF9?lang=en</a>.<p>\n        <p>(los datos aquí fueron complementados por ediciones anteriores de la base de datos).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>Utilizando los datos disponibles, el indicador se calcula reescalando primero, por separado, los ratios de densidad de personal sanitario para cada uno de los tres cuadros (médicos, psiquiatras y cirujanos) en relación con los valores mínimos observados en todos los países de la OCDE desde el año 2000, que son los siguientes: médicos = 0,9 por 1000, psiquiatras = 1 por 100.000 y cirujanos = 14 por 100.000. Este reajuste se realiza de la misma manera que el del indicador de densidad de camas hospitalarias descrito anteriormente, lo que da como resultado valores del indicador que van de 0 a 100 para cada uno de los tres cuadros. Por ejemplo, utilizando los datos del país sobre los médicos por cada 1000 habitantes (<em>x</em>), el indicador específico de los cuadros se calcularía como:</p>\n        <p>País con <em>x</em> &lt; 0,9 por 1000 al año, el indicador específico de cuadro = <em>x</em> /0,9*100.</p>\n        <p>País con <em>x</em> &gt;= 0,9 por 1000 al año, el indicador específico de cuadro = 100.</p>\n        <p>Como paso final, se calcula la media geométrica de los tres valores del indicador específico de cuadro para obtener el indicador final de densidad de personal sanitario.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>La categoría de &#x201C;médicos&#x201D; se ampliaría idealmente para incluir a todos los &#x201C;profesionales sanitarios básicos&#x201D;, como las enfermeras y las comadronas. Sin embargo, no existe ninguna base de datos comparable a nivel internacional que utilice definiciones coherentes de los profesionales sanitarios básicos no médicos para poder realizar comparaciones totalmente precisas entre países.</p>\n        <p>Para los países sin datos observados, la densidad de cirujanos se estimó a partir de una regresión que predice el logaritmo de cirujanos por cada 100.000, obtenida de la base de datos de la OMS descrita anteriormente, en función del logaritmo del PIB per cápita, estimado por el Banco Mundial.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Área del trazador</p>\n      </td>\n      <td>\n        <p>Seguridad sanitaria.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Definición del indicador</p>\n      </td>\n      <td>\n        <p>Índice de capacidad básica del Reglamento Sanitario Internacional (RSI), que es el porcentaje medio de atributos de 13 capacidades básicas que se han alcanzado en un momento determinado.</p>\n        <p>Las 13 capacidades básicas son: (1) Legislación, política y financiación nacional; (2) Coordinación y comunicaciones del Punto Focal Nacional; (3) Vigilancia; (4) Respuesta; (5) Preparación; (6) Comunicación de riesgos; (7) Recursos humanos; (8) Laboratorio; (9) Puntos de entrada; (10) Eventos zoonóticos; (11) Seguridad alimentaria; (12) Eventos químicos; (13) Emergencias radionucleares.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numerador</p>\n      </td>\n      <td>\n        <p>Número de atributos alcanzados.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Denominador</p>\n      </td>\n      <td>\n        <p>Número total de atributos.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Principales fuentes de datos</p>\n      </td>\n      <td>\n        <p>Encuesta a informantes clave.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de medición</p>\n      </td>\n      <td>\n        <p>Los informantes clave informan sobre el logro de un conjunto de atributos para cada una de las 13 capacidades básicas utilizando un instrumento estándar de la OMS, como se describe aquí: <a href=\"http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf\">http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf</a>.</p>\n        <p>Los valores de los indicadores a nivel de capacidad se pueden encontrar aquí:</p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en\">http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Método de estimación</p>\n      </td>\n      <td>\n        <p>El indicador se calcula promediando, entre las 13 capacidades básicas, el porcentaje de atributos de cada capacidad que se han alcanzado.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notas relacionadas con la CSU</p>\n      </td>\n      <td>\n        <p>Los países comenzaron a informar a la OMS sobre el logro de la capacidad básica del RSI para el año 2010. Se utiliza la puntuación del RSI más antigua disponible para cada país para todos los años 2000-2009.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>","fr":"<p>Objectif 3 : Permettre à tous de vivre en bonne santé et promouvoir le bien-être de tous à tout âge</p><p>Cible 3.8 : Faire en sorte que chacun bénéficie d’une couverture sanitaire universelle, comprenant une protection contre les risques financiers et donnant accès à des services de santé essentiels de qualité et à des médicaments et vaccins essentiels sûrs, efficaces, de qualité et à coût abordable</p><p>Indicateur 3.8.1 : Couverture des services de santé essentiels</p><p>Dernière mise à jour : Mars 2020 </p><h1>Indicateurs connexes en date de février 2020</h1>\n<p>L’indice de couverture des services de santé est conçu pour résumer les indicateurs existants de la couverture des services de santé afin d’assurer l’uniformité avec les ODD et d’autres initiatives mondiales et de réduire les doublons et le fardeau de déclaration. À l’heure actuelle, deux autres indicateurs des ODD sont inclus dans l’indice (3.a.1 et 3.d.1). </p>\n<p>L’indicateur 3.8.1 doit toujours être interprété avec l’autre indicateur de couverture sanitaire universelle des ODD, 3.8.2, qui mesure la protection financière. </p><h1>Informations institutionnelles</h1>\n<h2>Organisation(s) :</h2>\n<p>Organisation mondiale de la Santé (OMS) </p><h1>Concepts et définitions</h1>\n<h2>Définition :</h2>\n<p>La couverture des services de santé essentiels (définie comme la couverture moyenne des services essentiels basée sur des interventions de traçage qui incluent la santé génésique, maternelle, néonatale et infantile, les maladies infectieuses, les maladies non transmissibles et la capacité et l’accès aux services, parmi la population générale et la population la plus défavorisée). </p>\n<p>L’indicateur est un indice rapporté sur une échelle unitaire de 0 à 100, qui est calculé comme la moyenne géométrique de 14 indicateurs traceurs de la couverture des services de santé. </p>\n<h2>Concepts :</h2>\n<p>L’indice de la couverture des services de santé est calculé comme la moyenne géométrique de 14 indicateurs traceurs. Les 14 indicateurs sont énumérés ci-dessous et des métadonnées détaillées pour chacun des composants sont données en ligne (<a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf\">(en anglais) http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf</a>) et à l’annexe 1. Les indicateurs traceurs sont les suivants, organisés par quatre grandes catégories de couverture des services :</p>\n<p> <strong> <em>I. Santé reproductive, maternelle, néonatale et infantile</em></strong></p>\n<p> 1. <strong>Planification familiale</strong> : Pourcentage de femmes en âge de procréer (15 à 49 ans) mariées ou en union libre qui ont besoin d’une planification familiale satisfaite par des méthodes modernes </p>\n<p> 2. <strong>Soins de grossesse et d’accouchement</strong> : Pourcentage de femmes âgées de 15 à 49 ans ayant accouché (naissance vivante) au cours d’une période donnée et qui ont reçu des soins prénatals quatre fois ou plus</p>\n<p> 3. <strong>Vaccination des enfants</strong> : Pourcentage de nourrissons recevant trois doses du vaccin diphtérie-tétanos-coqueluche</p>\n<p> 4. <strong>Traitement de l’enfant</strong> : Pourcentage d’enfants de moins de 5 ans qu'on considère atteints d’une pneumonie (toux et respiration difficile NON en raison d’un problème dans la poitrine et d'un nez obstrué) dans les deux semaines précédant l’enquête et qui ont été amenés dans un établissement ou fournisseur de santé approprié</p>\n<p> <strong> <em>II. Maladies infectieuses</em></strong></p>\n<p> 5. <strong>Tuberculose</strong> : Pourcentage de cas de tuberculose détectés et traités avec succès</p>\n<p> 6. <strong>VIH/sida</strong> : Pourcentage de personnes vivant avec le VIH qui reçoivent actuellement un traitement antirétroviral</p>\n<p> 7. <strong>Malaria (paludisme)</strong> : Pourcentage de la population dans les zones où le paludisme est endémique qui dormait sous une moustiquaire imprégnée d’insecticide la nuit précédente (seulement pour les pays où le fardeau de paludisme est élevé)</p>\n<p> 8. <strong>Eau et système sanitaire</strong> : Pourcentage de ménages utilisant au moins des installations sanitaires de base</p>\n<p> <strong> <em>III. Maladies non transmissibles</em></strong></p>\n<p> 9. <strong>Hypertension</strong> : Prévalence normalisée selon l’âge de la tension artérielle non élevée (tension artérielle systolique &lt;140 mm Hg ou tension artérielle diastolique &lt;90 mm Hg) chez les adultes âgés de 18 ans ou plus</p>\n<p>10. <strong>Diabète</strong> : Glucose plasmatique moyen à jeun normalisé par âge (mmol/L) pour les adultes âgés de 18 ans ou plus</p>\n<p>11. <strong>Tabac</strong> : Prévalence normalisée selon l’âge des adultes d'au moins 15 ans n'ayant pas fumé de tabac au cours des 30 derniers jours (indicateur des ODD 3.a.1, métadonnées disponibles <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0a-01.pdf\">ici</a>)</p>\n<p> <strong> <em>IV. Capacité de service et accès</em></strong></p>\n<p>12. <strong>Accès à l’hôpital</strong> : Lits d’hôpital par habitant, par rapport à un seuil maximum de 18 pour 10 000 habitants</p>\n<p>13. <strong>Personnel de santé</strong> : Professionnels de la santé (médecins, psychiatres et chirurgiens) par habitant, par rapport aux seuils maximaux pour chaque groupe (chevauchement partiel avec l’indicateur des ODD 3.c.1, voir métadonnées <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0C-01.pdf\">ici</a>)</p>\n<p>14. <strong>Sécurité sanitaire</strong> : Indice de capacité de base du Règlement sanitaire international (RSI), qui est le pourcentage moyen d’attributs de 13 capacités de base qui ont été atteintes (indicateur des ODD 3.d.1, voir métadonnées <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0D-01.pdf\">ici</a>)</p><h1>Sources de données </h1>\n<h2>Description : </h2>\n<p>Bon nombre des indicateurs traceurs de la couverture des services de santé sont mesurés par des enquêtes auprès des ménages. Cependant, les données administratives, les données des établissements, les enquêtes sur les établissements et les systèmes de surveillance sentinelle sont utilisés pour certains indicateurs. Les sources de données sous-jacentes pour chacun des 14 indicateurs traceurs sont expliquées plus en détail à l'annexe 1. </p>\n<p>En termes de valeurs utilisées pour calculer l'indice, les valeurs sont tirées de sources publiées existantes. Cela comprend des ensembles de données assemblés et des estimations de diverses agences des Nations Unies. Ceci est résumé dans le lien ci-dessus. </p><h2>Processus de collecte :</h2>\n<p>Les mécanismes de collecte de données auprès des pays varient d’un pays à l’autre, mais dans de nombreux cas, une agence des Nations Unies ou un groupe interinstitutions a rassemblé et analysé des sources de données nationales pertinentes, puis a mené une consultation officielle auprès des gouvernements nationaux pour examiner ou produire des estimations comparables par pays. Pour l’indice de couverture des services de santé, une fois que ces informations existantes sur les 14 indicateurs traceurs sont rassemblées, l’OMS mène une consultation nationale avec les points focaux proposés par les gouvernements nationaux pour examiner les intrants et le calcul de l’indice. L’OMS n’entreprend pas de nouvelles activités d’estimation pour produire des valeurs d’indicateurs traceurs pour l’indice de couverture des services; l’indice est plutôt conçu pour utiliser les séries de données d’indicateurs existantes et bien établies afin de réduire le fardeau de déclaration. </p><h1>Calendrier </h1>\n<h2>Collecte de données : </h2>\n<p>La collecte de données varie de 1 à 5 ans selon les indicateurs de suivi. Par exemple, les données nationales sur la vaccination et le traitement du VIH sont communiquées chaque année, tandis que des enquêtes auprès des ménages pour recueillir des informations sur le traitement des enfants peuvent avoir lieu tous les 3 à 5 ans, selon le pays. De plus amples détails sur les indicateurs traceurs individuels sont disponibles à l'annexe 1. </p><h2>Diffusion des données : </h2>\n<p>La première diffusion des valeurs de référence de l'indice de couverture des services de la couverture sanitaire universelle a eu lieu en décembre 2017. On prévoit une mise à jour publiée en septembre 2019. </p><h1>Fournisseurs de données</h1>\n<p>Dans la plupart des cas, les ministères de la santé et les bureaux nationaux de statistique supervisent la collecte de données et les rapports sur les indicateurs de couverture des services de santé. </p><h1>Compilateurs de données</h1>\n<p>L’Organisation mondiale de la Santé, en s’appuyant sur les contributions d’autres organismes internationaux. </p><h2>Justification :</h2>\n<p>L’objectif 3.8 est défini comme « Faire en sorte que chacun bénéficie d’une couverture sanitaire universelle, comprenant une protection contre les risques financiers et donnant accès à des services de santé essentiels de qualité et à des médicaments et vaccins essentiels sûrs, efficaces, de qualité et à coût abordable ». La préoccupation est liée au fait que toutes les personnes et toutes les communautés doivent recevoir les services de santé de qualité dont elles ont besoin (y compris les médicaments et autres produits de santé), sans difficultés financières. Deux indicateurs ont été choisis pour surveiller l’objectif 3.8 dans le cadre des ODD. L’indicateur 3.8.1 porte sur la couverture des services de santé et l’indicateur 3.8.2 met l’accent sur les dépenses de santé par rapport au budget d’un ménage afin d’identifier les difficultés financières causées par les paiements directs de soins de santé. Pris dans leur ensemble, les indicateurs 3.8.1 et 3.8.2 visent à saisir les dimensions de la couverture des services et de la protection financière, respectivement, de l’objectif 3.8. Ces deux indicateurs doivent toujours être surveillés conjointement. </p>\n<p>Les pays fournissent de nombreux services essentiels pour la protection de la santé, la promotion, la prévention, le traitement et les soins. Les indicateurs de la couverture des services – définis comme les personnes qui reçoivent le service dont elles ont besoin – sont le meilleur moyen de suivre les progrès réalisés dans la prestation de services dans le cadre de la couverture sanitaire universelle (CSU). Étant donné qu’un seul indicateur des services de santé ne suffit pas pour la surveillance de la CSU, un indice est construit à partir de 14 indicateurs traceurs sélectionnés en fonction de critères épidémiologiques et statistiques. Cela comprend plusieurs indicateurs qui sont déjà inclus dans d’autres cibles des ODD, réduisant ainsi au minimum le fardeau de la collecte et de la production de rapports de données. L’indice est rapporté sur une échelle unitaire de 0 à 100, 100 étant la valeur optimale. </p><h2>Commentaires et limites :</h2>\n<p>Ces indicateurs traceurs sont censés indiquer la couverture des services, et non une liste complète ou exhaustive des services de santé et des interventions nécessaires à la couverture sanitaire universelle. Les 14 indicateurs traceurs ont été sélectionnés parce qu’ils sont bien établis, et les données disponibles sont largement déclarées par les pays (ou devraient bientôt être largement disponibles). Par conséquent, l’index peut être calculé avec les sources de données existantes et ne nécessite pas d’entreprendre de nouveaux efforts de collecte de données uniquement pour compléter l’index. </p><h1>Méthodologie</h1>\n<p><strong>Méthode de calcul : </strong></p>\n<p>L’indice est calculé avec des moyennes géométriques, basées sur les méthodes utilisées pour l’indice de développement humain. Le calcul de l’indicateur 3.8.1 nécessite d’abord de préparer les 14 indicateurs traceurs afin qu’ils puissent être combinés dans l’indice, puis de calculer l’indice à partir de ces valeurs. </p>\n<p>Les 14 indicateurs traceurs sont d’abord placés sur la même échelle, 0 étant la valeur la plus basse et 100 étant la valeur optimale. Pour la plupart des indicateurs, cette échelle est l’échelle naturelle de mesure, par exemple, le pourcentage de nourrissons vaccinés varie de 0 à 100%. Toutefois, pour quelques indicateurs, un changement d'échelle supplémentaire est nécessaire pour obtenir des valeurs appropriées de 0 à 100, comme suit : </p>\n<ul>\n  <li>Changement d'échelle basé sur un minimum non nul pour obtenir une résolution\nplus fine (ceci « étire » la répartition entre les pays) : la prévalence de la pression artérielle non élevée et la prévalence de la non-consommation de tabac sont toutes deux modifiées en utilisant une valeur minimale de 50%. <ul>\n      <li>valeur modifiée = (X-50)/(100-50)*100</li>\n    </ul>\n  </li>\n  <li>Changement d'échelle pour une mesure continue : le glucose plasmatique à jeun\nmoyen, qui est une mesure continue (unités de mmol/L), est converti en une échelle de 0 à 100 en utilisant le risque biologique théorique minimum (5,1 mmol/L) et observé maximum dans tous les pays (7,1 mmol/L). <ul>\n      <li>valeur modifiée = (7,1 - valeur originale)/(7,1-5,1)*100</li>\n    </ul>\n  </li>\n  <li>Seuils maximaux pour les indicateurs de taux : la densité des lits d’hôpital\net la densité du personnel de santé sont tous deux plafonnés à des seuils maximaux, et les valeurs supérieures à ces seuils sont maintenues constantes à 100. Ces seuils sont basés sur les valeurs minimales observées dans les pays de l’OCDE. Les valeurs modifiées sont les suivantes pour chaque indicateur :<ul>\n      <li>lits d’hôpital pour 10 000 habitants = minimum (100, valeur originale\n/ 18*100)</li>\n      <li>médecins pour 1 000 habitants = minimum (100, valeur originale / 0,9*100)</li>\n      <li>psychiatres pour 100 000 habitants = minimum (100, valeur originale /\n1*100)</li>\n      <li>chirurgiens pour 100 000 habitants = minimum (100, valeur originale /\n14*100)</li>\n    </ul>\n  </li>\n</ul>\n<p>Une fois que toutes les valeurs des indicateurs traceurs sont sur une échelle de 0 à 100, les moyennes géométriques sont calculées dans chacun des quatre domaines des services de santé, puis une moyenne géométrique est calculée à partir de ces quatre valeurs. Si la valeur d’un indicateur traceur est nulle, il est mis à 1 (sur 100) avant de calculer la moyenne géométrique. Le diagramme suivant illustre les calculs.</p>\n<p><img src=\"data:image/png;base64,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\"></p>\n<p>Il faut noter que pour les pays avec un bas fardeau de paludisme, l'indicateur traceur pour l'utilisation d'une moustiquaire imprégnée d'insecticide est retiré du calcul.</p><h2>Traitement des valeurs manquantes :</h2>\n<ul>\n  <li> <strong> <em>Au niveau national :</em></strong></li>\n</ul>\n<p>Le point de départ pour calculer l’index est d’assembler les informations existantes pour chaque indicateur traceur. Dans de nombreux cas, il s’agit d’utiliser des séries chronologiques par pays qui ont été produites ou rassemblées par les agences des Nations Unies en consultation avec les gouvernements nationaux (p. ex., couverture vaccinale, accès à un système sanitaire, couverture du traitement du VIH, etc.). Certaines de ces séries chronologiques publiées impliquent une modélisation mathématique pour réconcilier plusieurs sources de données ou imputer les valeurs manquantes, et ces détails sont résumés à l’annexe 1. </p>\n<p>Après avoir rassemblé ces intrants, il manque encore des valeurs pour certaines années par pays pour certains indicateurs. Le calcul de l’indice de couverture des services pour la CSU nécessite des valeurs pour chaque indicateur traceur pour un pays, de sorte qu’une certaine imputation est nécessaire pour combler ces lacunes de données. L’approche actuelle implique un algorithme d’imputation simple. Pour chaque indicateur :</p>\n<ul>\n  <li>\n    <ul>\n      <li>Si un pays a des valeurs manquantes entre deux années pour lesquelles\non a des valeurs, l’interpolation linéaire est utilisée pour remplir les valeurs manquantes pour les années intermédiaires</li>\n      <li>Si un pays a des valeurs historiques, mais aucune valeur actuelle, l’extrapolation\nconstante est utilisée pour remplir les valeurs manquantes de l’année en cours</li>\n      <li>Si un pays n’a pas de valeurs, une valeur est imputée. Pour la recherche\nde soins et la densité des chirurgiens en cas de pneumonie, une régression convient pour imputer les valeurs manquantes (voir l’annexe 1 pour plus de détails). Pour tous les autres indicateurs, une médiane régionale est calculée pour imputer les valeurs manquantes. Les régions sont basées sur les régions géographiques de la Banque mondiale, avec un groupe distinct pour les pays traditionnellement à revenu élevé<sup><a href=\"#footnote-1\" id=\"footnote-ref-1\">[1]</a></sup> </li>\n    </ul>\n  </li>\n</ul>\n<p>Compte tenu du calendrier et de la distribution de diverses enquêtes sur la santé et d’autres mécanismes de collecte de données, les pays ne recueillent pas et ne font pas rapport sur les 14 indicateurs traceurs de la couverture des services de santé sur une base annuelle. En outre, la surveillance au niveau des pays se fait le mieux à des intervalles de temps plus larges, par exemple tous les cinq ans, afin de permettre la collecte de nouvelles données entre les indicateurs. Par conséquent, la mesure dans laquelle l’imputation a été utilisée pour imputer les valeurs manquantes doit être déclarée avec la valeur de l’indice. </p>\n<ul>\n  <li> <strong> <em>Aux niveaux régional et mondial :</em></strong></li>\n</ul>\n<p>Toute imputation nécessaire se fait au niveau des pays. Ces valeurs nationales peuvent ensuite être utilisées pour calculer les valeurs régionales et mondiales. </p> <div class=\"footnotes\"> <div> <sup class=\"footnote-number\" id=\"footnote-1\">1</sup><p> Argentine, Australie, Autriche, Belgique, Brunei Darussalam, Canada, Chili, Chypre, Tchéquie, Danemark, Estonie, Finlande, France, Allemagne, Grèce, Islande, Irlande, Israël, Italie, Japon, Luxembourg, Malte, Pays-Bas, Nouvelle-Zélande, Norvège, Pologne, Portugal, République de Corée, Singapour, Slovaquie, Slovénie, Espagne, Suède, Suisse, Royaume-Uni, États-Unis d’Amérique, Uruguay <a href=\"#footnote-ref-1\">&#x2191;</a></p></div></div><h2>Agrégats régionaux : </h2>\n<p>Les agrégats régionaux et mondiaux sont calculés en utilisant la taille de la population nationale pour calculer une moyenne pondérée des valeurs spécifiques nationales pour l'indice. Cela se justifie par le fait que la CSU est une propriété des pays et que l'indice des services essentiels est une mesure sommaire de l'accès aux services essentiels pour la population de chaque pays. </p><h1>Disponibilité des données </h1>\n<h2>Description : </h2>\n<p>Résumer la disponibilité des données pour l'indice de couverture des services de CSU n'est pas simple, car différentes sources de données sont utilisées pour les 14 indicateurs traceurs. En outre, pour de nombreux indicateurs, des estimations comparables ont été produites, dans de nombreux cas en s'appuyant sur différents types de sources de données sous-jacentes pour éclairer les estimations tout en utilisant également des projections pour imputer les valeurs manquantes. Sur la base des sources de données sous-jacentes pour chacun des indicateurs traceurs (c'est-à-dire en ignorant les estimations et les projections), la proportion moyenne d'indicateurs utilisés pour calculer l'indice avec les données sous-jacentes disponibles depuis 2010 est d'environ 70% dans l'ensemble des pays. </p>\n<h2>Séries chronologiques : </h2>\n<p>Une valeur de référence de l'indice de couverture des services de CSU pour 2015 dans 183 pays a été publiée fin 2017. Dans le cadre de ce processus, des sources de données remontant à 2000 ont été rassemblées. En 2019, il est prévu de publier des séries chronologiques de 2000 à 2017. </p>\n<h2>Désagrégation : </h2>\n<p>L'équité est au cœur de la définition de la CSU, et par conséquent, l'indice de couverture des services de CSU devrait être utilisé pour communiquer des informations sur les inégalités de couverture des services dans les pays. Cela peut être fait en présentant l'indice séparément pour la population nationale par rapport aux populations défavorisées afin de mettre en évidence les différences entre elles. </p>\n<p>Pour les pays, l'emplacement géographique est probablement la dimension la plus réalisable pour la désagrégation infranationale basée sur les niveaux de couverture moyens mesurés avec les sources de données existantes. Pour ce faire, l'indice de CSU peut être calculé séparément, par exemple, par province ou résidence urbaine vs rurale, ce qui permettrait des comparaisons infranationales de la couverture des services. À l'heure actuelle, les données les plus facilement disponibles pour la ventilation sur d'autres dimensions de l'inégalité, telles que la richesse des ménages, concernent les indicateurs de couverture dans la catégorie des services de santé génésique, maternelle, néonatale et infantile. Les inégalités observées dans cette dimension peuvent être utilisées comme approximation pour comprendre les différences de couverture des services entre les dimensions clés de l'inégalité. Cette approche devrait être remplacée par une désagrégation complète des 14 indicateurs traceurs une fois que les données seront disponibles pour ce faire. </p><h2>Sources des divergences : </h2>\n<p>L'indice de couverture des services s'appuie sur des données et des estimations disponibles publiquement pour les indicateurs traceurs. Ces chiffres ont déjà fait l'objet d'un processus de consultation dans le pays (par exemple, pour la couverture vaccinale) ou sont tirés directement des données déclarées par le pays. </p><p>(Toutes les références sont en anglais, à moins d'indication contraire)</p>\n<h1>Références</h1>\n<h2><strong>URL : </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<h2><strong>Références : </strong></h2>\n<p>Rapport mondial de suivi 2017 : la couverture-santé universelle <a href=\"https://www.who.int/fr/publications/i/item/WHO-HIS-HGF-17.2\">https://www.who.int/fr/publications/i/item/WHO-HIS-HGF-17.2</a></p>\n<p><a href=\"http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf\">http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<p>Pour le développement historique de méthodes, consulter :</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1\">http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1</a> (remplacé par le document)</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/</a></p>\n<p><a href=\"http://collections.plos.org/uhc2014\">http://collections.plos.org/uhc2014</a></p>\n<h1>Annexe 1: Metadonnées pour les indicateurs traceurs utilisés pour mesurer la couverture des services de santé essentiels pour suivre l'indicateur des ODD 3.8.1.</h1>\n<p>Veuillez envoyer vos commentaires ou requêtes à l'adresse : <a href=\"mailto:uhc_stats@who.int\">uhc_stats@who.int</a></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Planification familiale</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de femmes en âge de procréer (15 à 49 ans) mariées ou en\nunion libre qui ont besoin d’une planification familiale satisfaite par des méthodes modernes.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre de femmes âgées de 15 à 49 ans, mariées ou en union libre, qui\nutilisent des méthodes modernes</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre total de femmes âgées de 15 à 49 ans, mariées ou en union libre,\nqui ont besoin de planification familiale</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquête de populaiton sur la santé</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les enquêtes auprès des ménages comprennent une série de questions pour\nmesurer le taux de prévalence de la contraception moderne et la demande de planification familiale. La demande totale de planification familiale est définie comme la somme du nombre de femmes en âge de procréer (15-49 ans) qui sont mariées ou en union libre et qui utilisent actuellement, ou dont le partenaire sexuel utilise actuellement, au moins une méthode contraceptive , et le besoin non satisfait de planification familiale. Le besoin non satisfait de planification familiale est la proportion de femmes en âge de procréer (15-49 ans) mariées ou en union libre, qui sont fécondes et sexuellement actives mais qui n'utilisent aucune méthode de contraception (moderne ou traditionnelle) et qui déclarent ne plus vouloir d'enfant ou vouloir retarder la naissance de leur prochain enfant d'au moins deux ans. Sont incluses :</p>\n        <p>toutes les femmes enceintes (mariées ou en union libre) dont les grossesses\nétaient non désirées ou inopportunes au moment de la conception;</p>\n        <p>toutes les femmes en aménorrhée post-partum (mariées ou en union libre)\nqui n'utilisent pas la planification familiale et dont le dernier accouchement n'était pas désiré ou inopportun;</p>\n        <p>toutes les femmes fécondes (mariées ou en union libre) qui ne sont ni\nenceintes ni en aménorrhée post-partum, et qui soit ne veulent plus d'enfants (veulent limiter la taille de la famille), soit qui souhaitent reporter la naissance d'un enfant d'au moins deux ans ou ne savent pas quand ou si elles veulent un autre enfant (veulent espacer les naissances), mais n'utilisent aucune méthode contraceptive.</p>\n        <p>Les méthodes modernes comprennent la stérilisation féminine et masculine,\nle dispositif intra-utérin (DIU), l'implant, les injectables, les pilules contraceptives orales, les préservatifs masculins et féminins, les méthodes de barrière vaginale (y compris le diaphragme, la cape cervicale et la mousse spermicide, la gelée, la crème et l'éponge), la méthode de l'allaitement maternel et de l'aménorrhée (MAMA), la contraception d'urgence et d'autres méthodes modernes non déclarées séparément.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>La Division de la population des Nations Unies produit une série systématique\net complète d'estimations et de projections annuelles du pourcentage de la demande de planification familiale qui est satisfaite chez les femmes mariées ou en union libre. Un modèle hiérarchique bayésien combiné à des données spécifiques au pays est utilisé pour générer les estimations, les projections et les évaluations de l'incertitude à partir des données d'enquête. Le modèle tient compte des différences selon la source de données, l'échantillon de population et les méthodes contraceptives. </p>\n        <p>Pour plus de détails, consulter : <a href=\"http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml\">http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td></td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Soins de grossesse et d’accouchement</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de femmes âgées de 15 à 49 ans ayant accouché (naissance\nvivante) au cours d’une période donnée et qui ont reçu des soins prénatals quatre fois ou plus </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre de femmes âgées de 15 à 49 ans ayant accouché (naissance vivante)\nau cours d’une période donnée et qui ont reçu des soins prénatals quatre fois ou plus</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre total de femmes âgées de 15 à 49 ans ayant accouché (naissance\nvivante) au cours de cette même période</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes auprès des ménages et système d'information de routine des établissements</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les données sur quatre consultations prénatales ou plus sont basées sur\ndes questions qui demandent si et combien de fois la santé de la femme a été contrôlée pendant la grossesse. Les enquêtes auprès des ménages qui peuvent générer cet indicateur comprennent les EDS, MICS, RHS et d'autres enquêtes basées sur des méthodologies similaires. Les systèmes de notification des services/établissements peuvent être utilisés là où la couverture est élevée, généralement dans les pays à revenu élevé.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>L'OMS tient à jour une base de données sur la couverture des soins prénatals\n: <a href=\"http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4\">http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Idéalement, cet indicateur devrait être remplacé par une mesure plus\ncomplète des soins pendant la grossesse et l'accouchement, par exemple la proportion de femmes qui ont un prestataire qualifié pour assister à l'accouchement ou à un accouchement en institution. Un défi dans la mesure de l'assistance qualifiée à l'accouchement consiste à déterminer quels prestataires sont « qualifiés ». </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<p><br></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Vaccination des enfants</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de nourrissons recevant trois doses du vaccin diphtérie-tétanos-coqueluche</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre d'enfants de 1 an ayant reçu trois doses du vaccin diphtérie-tétanos-coqueluche</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre total d'enfants de 1 an</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes auprès des ménages et système d'information de routine des établissements</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Pour les données d'enquête, le statut vaccinal des enfants âgés de 12\nà 23 mois est recueilli à partir des carnets de santé de l'enfant ou, à défaut de carnet, à partir du rappel par la personne en charge de l'enfant. Pour les données administratives, le nombre total de doses administrées à la population cible est extrait.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Ensemble, l'OMS et l'UNICEF dérivent des estimations de la couverture\ndu DTC3 sur la base des données officiellement communiquées à l'OMS et à l'UNICEF par les États membres, ainsi que des données déclarées dans la littérature publiée et la littérature grise. Ils consultent également des experts locaux - principalement les responsables nationaux du Programme étendu de vaccination et le personnel des bureaux régionaux de l'OMS - pour obtenir des informations supplémentaires concernant la performance de services de vaccination locaux spécifiques. Sur la base des données disponibles, de la prise en compte des biais potentiels et des contributions d'experts locaux, l'OMS/UNICEF détermine le niveau réel le plus probable de couverture vaccinale. </p>\n        <p>Pour plus de détails, consulter : </p>\n        <p><a href=\"http://www.who.int/bulletin/volumes/87/7/08-053819/en/\">http://www.who.int/bulletin/volumes/87/7/08-053819/en/</a></p>\n        <p><a href=\"http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html\">http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Les calendriers nationaux de vaccination varient d'un pays à l'autre.\nCompte tenu de cela, une option pour surveiller la vaccination complète des enfants consiste à surveiller la fraction d'enfants recevant des vaccins inclus dans le calendrier national de leur pays. Une deuxième option, qui peut être plus comparable d'un pays à l'autre et dans le temps, consiste à surveiller la couverture par le DTC3 comme indicateur indirect de la vaccination complète des enfants. Le vaccin contenant la diphtérie, le tétanos et la coqueluche comprend souvent d'autres vaccins, par exemple contre l'hépatite B et l'Haemophilus influenza de type B, et constitue une mesure raisonnable à savoir s'il existe une plate-forme de distribution de vaccins robuste dans un pays.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Traitement de l’enfant (recherche de soins pour des symptômes de pneumonie)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage d’enfants de moins de 5 ans qu'on considère atteints d’une\npneumonie (toux et respiration difficile NON en raison d’un problème dans la poitrine et d'un nez obstrué) dans les deux semaines précédant l’enquête et qui ont été amenés dans un établissement ou fournisseur de santé approprié.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre d’enfants qu'on considère atteints d’une pneumonie dans les deux\nsemaines précédant l’enquête et qui ont été amenés dans un établissement de santé approprié</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre d’enfants qu'on considère atteints d’une pneumonie dans les deux\nsemaines précédant l’enquête</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes auprès des ménages</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Au cours de la réunion sur les indicateurs de survie de l'enfant basés\nsur les enquêtes, de UNICEF/OMS, tenue à New York, les 17 et 18 juin 2004, il a été recommandé que les infections respiratoires aiguës (IRA) soient décrites comme une « pneumonie présumée » afin de mieux refléter la cause probable et les interventions recommandées. La définition de la pneumonie présumée utilisée dans les Enquêtes démographiques et de santé (EDS) et dans les Enquêtes en grappes à indicateurs multiples (MICS) a été choisie par le groupe et est basée sur la perception des mères d'un enfant qui tousse, respire plus vite que d'habitude avec des respirations courtes et rapides ou ayant des difficultés à respirer, à l'exclusion des enfants qui n'avaient que le nez bouché. La définition du prestataire de soins approprié varie d'un pays à l'autre.</p>\n        <p>L'OMS maintient une base de données d'observations au niveau des pays,\nà partir d'enquêtes auprès des ménages qui peut être consultée à l'adresse : <a href=\"http://apps.who.int/gho/data/node.main.38?lang=en\">http://apps.who.int/gho/data/node.main.38?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Il n'existe actuellement aucune estimation comparable au niveau international\npour cet indicateur.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Cet indicateur n'est généralement pas mesuré dans les pays à revenu élevé\ndotés de systèmes de santé bien établis. </p>\n        <p>Pour les pays sans données observées, la couverture a été estimée à partir\nd'une régression qui prédit la couverture de la recherche de soins pour des symptômes de pneumonie (sur l'échelle logit), obtenue à partir de la base de données de l'OMS décrite ci-dessus, en fonction du log de l'estimation du taux de mortalité par pneumonie chez les moins de 5 ans, que vous pouvez trouver à l'adresse : <a href=\"https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html\">https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html</a></p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Traitement pour la tuberculose</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de cas de tuberculose détectés et traités avec succès dans\nune année donnée</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre de nouveaux cas et de cas de rechute détectés au cours d'une année\ndonnée et traités avec succès</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre de nouveaux cas et de cas de rechute détectés au cours de cette\nmême année</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Systèmes d'information des établissements, systèmes de surveillance,\nenquêtes de santé basées sur la population avec tests de diagnostic de la tuberculose, registre de la tuberculose et système de notification trimestriel connexe (ou registres électroniques de la tuberculose)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Cet indicateur nécessite trois entrées principales :</p>\n        <p>(1) Le nombre de nouveaux cas de tuberculose et de cas de rechute diagnostiqués\net traités dans les programmes nationaux de lutte contre la tuberculose et déclarés à l'OMS au cours d'une année donnée .</p>\n        <p>(2) Le nombre de cas de tuberculose pour la même année, généralement\nestimé par l'OMS .</p>\n        <p>(3) Pourcentage de cas de tuberculose traités avec succès (guérison plus\ntraitement terminé) parmi les cas de tuberculose déclarés aux autorités sanitaires nationales .</p>\n        <p>L'indicateur final = (1)/(2) x (3)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Les estimations de l'incidence de la tuberculose sont produites dans\nle cadre d'un processus consultatif et analytique dirigé par l'OMS et sont publiées chaque année. Ces estimations sont basées sur les notifications annuelles de cas, les évaluations de la qualité et de la couverture des données de notification de la tuberculose, les enquêtes nationales sur la prévalence de la tuberculose et les informations provenant des systèmes d'enregistrement des décès (état civil). Les estimations de l'incidence pour chaque pays sont dérivées, en utilisant une ou plusieurs des approches suivantes en fonction des données disponibles :</p>\n        <p>1. incidence = notifications de cas/proportion estimée de cas détectés;</p>\n        <p>2. incidence = prévalence/durée de la condition;</p>\n        <p>3. incidence = décès/proportion de cas qui résultent en décès. </p>\n        <p>Ces estimations de l'incidence de la tuberculose sont combinées avec\nles données déclarées par les pays sur le nombre de cas détectés et traités, et le pourcentage de cas traités avec succès, comme décrit ci-dessus. .</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Pour calculer l'indicateur à l'aide des estimations de l'OMS, on peut\naccéder aux fichiers nécessaires à l'adresse : <a href=\"http://www.who.int/tb/country/data/download/en/\">http://www.who.int/tb/country/data/download/en/</a>, et calculer l'indicateur comme étant = c_cdr x c_new_tsr</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Traitement pour le VIH</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de personnes vivant avec le VIH qui reçoivent actuellement\nun traitement antirétroviral</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre d'adultes et d'enfants qui recevaient un traitement antirétroviral\nà la fin de la période de référence</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre d'adultes et d'enfants vivant avec le VIH pendant la même période</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Systèmes de déclaration des établissements, sites de surveillance sentinelle,\nenquêtes basées sur la population </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Numérateur: Le numérateur peut être généré en comptant le nombre d'adultes\net d'enfants qui ont reçu une polythérapie antirétrovirale à la fin de la période de référence. Les données peuvent être recueillies à partir des registres de traitement antirétroviral des établissements ou des systèmes de gestion de l'approvisionnement en médicaments. Ceux-ci sont ensuite comptabilisés et transférés dans des rapports mensuels ou trimestriels transversaux qui peuvent ensuite être agrégés pour obtenir des totaux nationaux. Les patients recevant un traitement antirétroviral dans le secteur privé et le secteur public doivent être inclus dans le numérateur.</p>\n        <p>Dénominateur: Les données sur le nombre de personnes infectées par le\nVIH peuvent provenir d'enquêtes basées sur la population ou, comme c'est souvent le cas en Afrique subsaharienne, de systèmes de surveillance basés sur des cliniques de soins prénatals.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Les estimations de la couverture du traitement antirétroviral chez les\npersonnes vivant avec le VIH pour 2000-2018 sont dérivées du cycle d'estimation 2019 de l'ONUSIDA. </p>\n        <p>Pour estimer le nombre de personnes vivant avec le VIH au fil du temps\ndans les pays à forte charge, l'ONUSIDA, en collaboration avec les pays, utilise un modèle épidémique (Spectrum) qui combine les données de surveillance sur la prévalence avec le nombre actuel de patients recevant un traitement antirétroviral et des hypothèses sur l'histoire naturelle de l'évolution du VIH. </p>\n        <p>Étant donné que le traitement antirétroviral est désormais recommandé\npour toutes les personnes vivant avec le VIH, le suivi de la couverture de ce traitement est moins compliqué qu'auparavant, alors que seules les personnes présentant un certain niveau de gravité de la maladie étaient éligibles pour recevoir ce traitement.</p>\n        <p>Les estimations de la couverture du traitement antirétroviral sont disponibles\nà l'adresse : http://aidsinfo.unaids.org/</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Des estimations comparables de la couverture du traitement antirétroviral\ndans les pays à revenu élevé, en particulier les tendances temporelles, ne sont pas toujours disponibles .</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Prévention du paludisme (malaria)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de la population dans les zones où le paludisme est endémique\nqui dormait sous une moustiquaire imprégnée d’insecticide la nuit précédente.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre de personnes dans les zones où le paludisme est endémique qui\ndormaient sous une moustiquaire imprégnée d’insecticide.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre total de personnes dans les zones où le paludisme est endémique.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Les données sur l'accès et l'utilisation des moustiquaires imprégnées\nd’insecticide (MII) par les ménages proviennent d'enquêtes auprès des ménages représentatives au niveau national telles que les enquêtes démographiques et de santé, les enquêtes en grappes à indicateurs multiples et les enquêtes sur les indicateurs du paludisme. Les données sur le nombre de MII livrées par les fabricants aux pays sont compilées par « Milliner Global Associates », et les données sur le nombre de MII distribuées dans les pays sont communiquées par les programmes nationaux de lutte contre le paludisme.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>De nombreuses enquêtes nationales récentes rapportent le nombre de MII\nobservées dans chaque ménage répondant. Les taux de possession peuvent être convertis en proportion de personnes dormant sous une MII en utilisant une relation linéaire entre l'accès et l'utilisation qui a été dérivée de 62 enquêtes qui recueillent des informations sur les deux indicateurs. </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Des modèles mathématiques peuvent être utilisés pour combiner les données\ndes enquêtes auprès des ménages sur l'accès et l'utilisation avec des informations sur les livraisons de MII par les fabricants et la distribution de MII par les programmes nationaux de lutte contre le paludisme afin de produire des estimations annuelles de la couverture en MII. L'OMS utilise cette approche en collaboration avec le « Malaria Atlas Project ». Les détails méthodologiques peuvent être trouvés dans l'annexe du Rapport mondial sur le paludisme 2015 : <a href=\"http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/\">http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>L'OMS produit des estimations comparables de la couverture en MII pour\n40 pays fortement touchés. Pour les autres pays, la couverture en MII n'est pas incluse dans l'indice de couverture des services pour la CSU en raison des limites des données. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Eau et système sanitaire</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Pourcentage de ménages utilisant au moins des installations sanitaires\nde base</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Population vivant dans un ménage avec : chasse d'eau vers un réseau d'égouts,\nune fosse septique ou des latrines à fosse; latrine à fosse ventilée améliorée; latrines à fosse avec dalle; ou toilettes à compost.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Population totale</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes auprès des ménages et recensements</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les réponses au niveau du ménage, pondérées par la taille du ménage,\nsont utilisées pour calculer la couverture de la population.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Le Programme conjoint de suivi OMS/UNICEF a produit des estimations régulières\nde la couverture d'au moins un système sanitaire de base pour le suivi des OMD. Après avoir compilé une base de données des sources de données disponibles, pour chaque pays, des régressions linéaires simples sont ajustées à la série de données du pays pour obtenir une estimation, ainsi que pour produire une extrapolation sur 2 ans au-delà du dernier point de données disponible, après quoi la couverture est maintenue constante pendant 4 ans, puis supposée manquante. Ceci est fait séparément pour les régions urbaines et rurales, puis combiné pour obtenir des estimations de la couverture nationale. Les détails de la méthodologie et les estimations les plus récentes peuvent être trouvés à l'adresse : http://www.wssinfo.org/</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>L'indicateur ODD au sujet de système sanitaire (ODD 6.2.1) est une version\nélargie de l'indicateur OMD, intégrant la qualité des installations d'assainissement. Il n'est pas pour la surveillance de la CSU en raison de la faible disponibilité des données. Un indicateur conjoint qui identifie la proportion de ménages ayant accès à la fois à l'eau potable et à un système sanitaire pourrait également être envisagé.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Prévention de maladie cardiovasculaire</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Prévalence normalisée selon l’âge de la tension artérielle normale chez\nles adultes âgés de 18 ans ou plus, quel que soit le statut du traitement</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre d'adultes âgés de 18 ans ou plus avec une tension artérielle systolique\n&lt; 140 mm Hg ou tension artérielle diastolique &lt; 90 mm Hg (quel que soit le statut du traitement)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre d'adultes âgés de 18 ans ou plus</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes basées sur la population et systèmes de surveillance</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les sources de données enregistrant la tension artérielle mesurée sont\nutilisées (les données autodéclarées sont exclues). Si plusieurs lectures de tension artérielle sont prises par participant, la première lecture est abandonnée et on fait la moyenne des lectures restantes.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Pour produire des estimations nationales comparables, les données d'observation\nde la prévalence définies en termes de seuils alternatifs de tension artérielle systolique et/ou diastolique sont converties en prévalence de l'hypertension artérielle, soit une tension artérielle systolique &gt; 140 mm Hg ou une tension artérielle diastolique &gt; 90 mm Hg, à l'aide d'équations de régression. Un modèle hiérarchique bayésien est ensuite ajusté à ces données pour calculer les prévalences spécifiques par âge-sexe-année-pays, qui tient compte des sources de données nationales par rapport aux sources de données infranationales, des sources de données urbaines par rapport aux rurales, et permet une variation de la prévalence selon l'âge et le sexe. Des estimations normalisées selon l'âge sont ensuite produites en appliquant les estimations brutes à la population type de l'OMS. Les détails sur les méthodes statistiques sont à l'adresse : <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext</a></p>\n        <p>L'OMS et le groupe « NCD Risk Factor Collaboration (NCD-RisC) » ont produit\ndes estimations comparables pour cet indicateur jusqu'à l'année 2015, qui sont disponibles à l'adresse : </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en\">http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Les estimations de prévalence sont converties en prévalence de tension\nartérielle normale pour être incorporées dans l'indice de la CSU, de sorte qu'une valeur de 100 % soit la cible optimale. Ceci est calculé comme suit : prévalence de la tension artérielle normale = 1 – prévalence de la tension artérielle élevée. Les estimations ci-dessus sont faites séparément pour les hommes et les femmes; pour l'indicateur traceur de la CSU, une simple moyenne des valeurs pour les hommes et les femmes est calculée.</p>\n        <p>La tension artérielle normale est la somme du pourcentage de personnes\nqui ne souffrent pas d'hypertension et du pourcentage de personnes dont l'hypertension est contrôlée par des médicaments. L'absence d'hypertension est le résultat d'efforts de prévention via la promotion de l'activité physique et d'une alimentation saine, ainsi que d'autres facteurs. L'hypertension contrôlée par des médicaments est le résultat d'un traitement efficace. Cet indicateur est donc un indicateur indirect de l'efficacité de la promotion de la santé et de l'efficacité des services médicaux. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Gestion du diabète</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Glucose plasmatique moyen à jeun normalisé par âge pour les adultes âgés\nde 18 ans ou plus</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes basées sur la population et systèmes de surveillance</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les niveaux de glucose plasmatique à jeun sont déterminés en prélevant\nun échantillon de sang de participants qui ont jeûné pendant au moins 8 heures. D'autres biomarqueurs apparentés, tels que l'hémoglobine A1c (HbA1c), ont été utilisés pour aider à calculer les estimations (voir ci-dessous).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>Pour produire des estimations nationales comparables, les observations\nde données basées sur le glucose plasmatique à jeun moyen, le test de tolérance au glucose oral (OGTT), l'HbA1c ou leurs combinaisons sont toutes converties en glucose plasmatique à jeun moyen. Un modèle hiérarchique bayésien est ensuite ajusté à ces données pour calculer les prévalences spécifiques par âge-sexe-année-pays, qui tient compte des sources de données nationales par rapport aux sources de données infranationales, des sources de données urbaines par rapport aux rurales, et permet une variation de la prévalence selon l'âge et le sexe. Des estimations normalisées selon l'âge sont ensuite produites en appliquant les estimations brutes à la population type de l'OMS. Les détails méthodologiques peuvent être trouvés dans le Rapport mondial sur le diabète à l'adresse : <a href=\"http://apps.who.int/iris/bitstream/handle/10665/254648/9789242565256-fre.pdf?sequence=1\">http://apps.who.int/iris/bitstream/handle/10665/254648/9789242565256-fre.pdf?sequence=1</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Le glucose plasmatique à jeun d'un individu peut être faible en raison\nd'un traitement efficace avec des médicaments hypoglycémiants, ou parce que l'individu n'est pas diabétique en raison d'activités de promotion de la santé ou d'autres facteurs tels que la génétique. Le glucose plasmatique à jeun moyen est donc un indicateur à la fois de la promotion efficace d'une alimentation et de comportements sains et d'un traitement efficace du diabète.</p>\n        <p>Les estimations ci-dessus sont produites séparément pour les hommes et\nles femmes; pour l'indicateur traceur de la CSU, une simple moyenne des valeurs pour les hommes et les femmes est calculée.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Contrôle du tabac</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Prévalence normalisée selon l’âge des adultes d'au moins 15 ans n'ayant\npas fumé de tabac au cours des 30 derniers jours </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre d'adultes d'au moins 15 ans n'ayant pas fumé de tabac au cours\ndes 30 derniers jours</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre d'adultes d'au moins 15 ans</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Enquêtes auprès des ménages</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>« Fumant actuellement du tabac » comprend les cigarettes, les cigares,\nles pipes ou tout autre produit du tabac fumé au cours des 30 derniers jours. Les données sont recueillies via l'auto-déclaration dans les enquêtes.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>L'OMS estime la prévalence du (non) tabagisme actuel avec un modèle de\nméta-régression binomiale négative, qui génère des estimations comparables en faisant un ajustement pour tenir compte des différences dans les groupes d'âge et de la définition des indicateurs dans les enquêtes nationales incluses dans l'analyse. Ces estimations sont faites séparément pour les hommes et les femmes. Les détails méthodologiques peuvent être trouvés à l'adresse : <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>La prévalence de ne pas fumer de tabac est calculée comme 1 moins la\nprévalence de fumer du tabac. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Accès à l’hôpital</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Indicator definition</p>\n      </td>\n      <td>\n        <p>Lits d’hôpital par habitant, par rapport à un seuil maximum de 18 pour\n10 000 habitants</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre de lits d'hôpital (devrait exclure les lits pour le travail et\npour l'accouchement)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Population totale </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Systèmes administratifs / Système de déclaration des établissements de\nsanté</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les systèmes administratifs des pays sont utilisés pour totaliser le\nnombre de lits d'hôpitaux, qui est divisé par la population totale estimée et multiplié par 10 000. </p>\n        <p>Les bureaux régionaux de l'OMS et d'autres groupes recueillent des informations\nsur la densité nationale des lits d'hôpitaux, y compris les ressources en ligne suivantes :</p>\n        <p><a href=\"https://rho.emro.who.int/rhodata/node.main.A36\">https://rho.emro.who.int/rhodata/node.main.A36</a></p>\n        <p>Observatoire régional de l'OMS « AFRO » : <a href=\"http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population\">http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population</a></p>\n        <p>Base de données de l'OMS « EURO European Health for All » : <a href=\"https://gateway.euro.who.int/en/datasets%20european-health-for-all-database/\">https://gateway.euro.who.int/en/datasets\neuropean-health-for-all-database/</a></p>\n        <p>OCDE: <a href=\"https://data.oecd.org/healtheqt/hospital-beds.htm\">https://data.oecd.org/healtheqt/hospital-beds.htm</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>À partir des données disponibles, l'indicateur est calculé par rapport\nà une valeur seuil de 18 lits d'hôpitaux pour 10 000 habitants. Ce seuil est inférieur au minimum observé pour les pays à revenu élevé de l'OCDE (depuis l'an 2000) de 20 pour 10 000 et tend à correspondre à un taux d'hospitalisation d'environ 5 pour 100 par an. Cet indicateur est conçu pour saisir les faibles niveaux de capacité hospitalière; le seuil maximal est utilisé parce que des densités de lits d'hôpitaux très élevées ne sont pas nécessaires à une utilisation efficace des ressources. L'indicateur est calculé comme suit, en utilisant les données nationales sur la densité des lits d'hôpitaux (<em>x</em>), ce qui donne des valeurs allant de 0 à 100 :</p>\n        <p>Pays avec une densité de lits d'hôpital <em>x</em> &lt; 18 pour 10 000\nhabitants, par année, l'indicateur = </p>\n        <p><em>x</em> /18*100. </p>\n        <p>Pays avec une densité de lits d'hôpital <em>x</em> &gt;= 18 pour 10 000\nhabitants, par année, l'indicateur = 100.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Un autre indicateur pourrait être le taux d'hospitalisation des patients,\npar rapport à un seuil maximal. Cependant, cet indicateur n'est actuellement pas largement déclaré dans toutes les régions, en particulier dans la région africaine. Dans les pays où les lits d'hôpitaux par habitant et les taux d'hospitalisation sont disponibles, ils sont fortement corrélés.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Personnel de santé</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Professionnels de la santé (médecins, psychiatres et chirurgiens) par\nhabitant, par rapport aux seuils maximaux pour chaque groupe</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre de médecins, psychiatres et chirurgiens</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Population totale</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Base de données ou registre national du personnel de santé, idéalement\nassocié à une évaluation régulière de l'exhaustivité à l'aide des données de recensement, des registres des associations professionnelles ou des recensements des établissements</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>La classification du personnel de santé est basée sur des critères d'enseignement\net de formation professionnels, de réglementation des professions de santé et d'activités et de tâches professionnelles, c'est-à-dire un cadre de catégorisation des variables clés de la main-d'œuvre en fonction de caractéristiques communes. Le cadre de l'OMS s'inspire largement des dernières révisions des systèmes de classification normalisés au niveau international de l'Organisation internationale du travail (Classification internationale type des professions), de l'Organisation des Nations Unies pour l'éducation, la science et la culture (Classification internationale type de l'éducation) et de la Division de la statistique des Nations Unies (Classification internationale type par industrie, de toutes les branches d'activité économique). </p>\n        <p>Les détails méthodologiques et les données peuvent être trouvés à l'adresse\n: <a href=\"http://www.who.int/hrh/statistics/hwfstats/en/\">http://www.who.int/hrh/statistics/hwfstats/en/</a></p>\n        <p>Les données proviennent des sources suivantes :</p>\n        <p>Médecins : <a href=\"http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en\">http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en</a></p>\n        <p>Psychiatres : <a href=\"https://www.who.int/fr/publications/i/item/WHO-HIS-HGF-17.2\">https://www.who.int/fr/publications/i/item/WHO-HIS-HGF-17.2</a></p>\n        <p>Chirurgiens : <a href=\"http://apps.who.int/gho/data/node.main.HWF9?lang=en%20\">http://apps.who.int/gho/data/node.main.HWF9?lang=en</a>\n</p>\n        <p>(ces données ont été complétées par des éditions antérieures de la base\nde données)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>À l'aide des données disponibles, l'indicateur est calculé en rééchelonnant\nd'abord, séparément, les ratios de densité du personnel de santé pour chacun des trois groupes (médecins, psychiatres et chirurgiens) par rapport aux valeurs minimales observées dans les pays de l'OCDE depuis 2000, qui sont les suivantes : médecins = 0,9 pour 1 000, psychiatres = 1 pour 100 000 et chirurgiens = 14 pour 100 000. Cette remise à l'échelle est effectuée de la même manière que pour l'indicateur de densité de lits d'hôpitaux décrit ci-dessus, ce qui donne des valeurs d'indicateur allant de 0 à 100 pour chacun des trois groupes. Par exemple, en utilisant les données nationales sur les médecins pour 1 000 habitants (<em>x</em>), l'indicateur spécifique au groupe serait calculé comme suit :</p>\n        <p>Pays avec <em>x</em> &lt; 0,9 pour 1 000 habitants, par année, l'indicateur\nspécifique à ce groupe = <em>x</em> /0.9*100. </p>\n        <p>Pays avec <em>x</em> &gt;= 0,9 pour 1 000 habitants, par année, l'indicateur\nspécifique à ce groupe = 100.</p>\n        <p>Dans une dernière étape, la moyenne géométrique des trois valeurs d'indicateur\nspécifique à chaque groupe est calculée pour obtenir l'indicateur final de la densité des effectifs de santé.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>La catégorie « médecins » serait idéalement élargie pour inclure tous\nles « professionnels de la santé de base », tels que les infirmières et les sages-femmes. Cependant, il n'existe aucune base de données internationalement comparable qui utilise des définitions cohérentes des principaux professionnels de la santé non médecins pour permettre des comparaisons précises entre les pays.  </p>\n        <p>Pour les pays sans données observées, la densité de chirurgiens a été\nestimée à partir d'une régression qui prédit le log de chirurgiens pour 100 000 habitants, obtenu à partir de la base de données de l'OMS décrite ci-dessus, exprimé comme une fonction du log du PIB par habitant, tel qu'estimé par la Banque mondiale.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Indicateur traceur</p>\n      </td>\n      <td>\n        <p>Sécurité sanitaire</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Définition de l'indicateur</p>\n      </td>\n      <td>\n        <p>Indice de capacité de base du Règlement sanitaire international (RSI),\nqui est le pourcentage moyen d’attributs de 13 capacités de base qui ont été atteintes à un moment précis. </p>\n        <p>Les 13 capacités de base sont : (1) Législation nationale, politique\net financement; (2) Coordination et communication du correspondant national ; (3) Surveillance; (4) Réponse; (5) État de préparation; (6) Communication des risques; (7) Ressources humaines; (8) Laboratoire; (9) Points d'entrée; (10) Événements zoonotiques; (11) Sécurité alimentaire; (12) Événements chimiques; (13) Urgences radionucléaires.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Numérateur</p>\n      </td>\n      <td>\n        <p>Nombre d'attributs atteints</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Dénominateur</p>\n      </td>\n      <td>\n        <p>Nombre total d'attributs</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Sources principales de données</p>\n      </td>\n      <td>\n        <p>Sondage auprès des informateurs clés</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode de mesure</p>\n      </td>\n      <td>\n        <p>Les informateurs clés rendent compte de la réalisation d'un ensemble\nd'attributs pour chacune des 13 capacités de base à l'aide d'un instrument standard de l'OMS, tel que décrit à l'adresse : <a href=\"http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf\">http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf</a></p>\n        <p>Les valeurs des indicateurs de niveau de capacité peuvent être trouvées\nà l'adresse : </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en\">http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Méthode d'estimation</p>\n      </td>\n      <td>\n        <p>L'indicateur est calculé en faisant la moyenne, sur les 13 capacités\nde base, du pourcentage d'attributs pour chaque capacité, qui ont été atteints.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Notes au sujet de la CSU</p>\n      </td>\n      <td>\n        <p>Les pays ont commencé à communiquer à l'OMS l'atteinte des capacités\nde base du RSI pour l'année 2010. Le premier score RSI disponible pour chaque pays est utilisé pour toutes les années 2000-2009.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>","pt":"","ru":"<p>Цель 3: Обеспечение здорового образа жизни и содействие благополучию для всех в любом возрасте</p><p>Задача 3.8: Обеспечить всеобщий охват услугами здравоохранения, в том числе защиту от финансовых рисков, доступ к качественным основным медико-санитарным услугам и доступ к безопасным, эффективным, качественным и недорогим основным лекарственным средствам и вакцинам для всех</p><p>Показатель 3.8.1: Охват основными медико-санитарными услугами (определяемый как средний охват основными услугами по отслеживаемым процедурам, к которым относятся охрана репродуктивного здоровья, охрана здоровья матери и ребенка, лечение инфекционных заболеваний, лечение неинфекционных заболеваний и масштабы и доступность услуг для широких слоев населения и для находящихся в наиболее неблагоприятном положении групп населения)</p><p>Последнее обновление: март 2020 года </p><h1> Связанные показатели по состоянию на февраль 2020 года </h1>\n<p>Индекс охвата услугами ВОУЗ (Всеобщий охват услугами здравоохранения) предназначен для обобщения существующих показателей охвата услугами здравоохранения, чтобы обеспечить согласованность с показателями ЦУР и другими глобальными инициативами и уменьшить дублирование и бремя отчетности. В настоящее время в индекс включены два других показателя ЦУР (3.a.1 и 3.d.1). </p>\n<p> Показатель 3.8.1 всегда следует интерпретировать вместе с другим показателем ЦУР 3.8.2, включенным в ВОУЗ, который оценивает финансовую защищенность.</p><h1> Институциональная информация </h1>\n<h2> Организация (и): </h2>\n<p> Всемирная организация здравоохранения (ВОЗ) </p><h1> Понятия и определения </h1>\n<h2> Определение: </h2>\n<p>Охват основными медицинскими услугами (определяется как среднее значение показателей охвата основными услугами, основанных на контрольных обследованиях, которые включают репродуктивное здоровье, здоровье матерей, новорожденных и детей, инфекционные заболевания, неинфекционные заболевания, а также потенциал услуг и доступ к услугам среди населения в целом и среди наиболее обездоленных слоев населения). </p>\n<p> Показатель представляет собой индекс, отражаемый на безразмерной шкале от 0 до 100, который вычисляется как среднее геометрическое значение 14 контрольных показателей охвата услугами здравоохранения. </p>\n<h2> Понятия: </h2>\n<p>Индекс охвата услугами здравоохранения рассчитывается как среднее геометрическое значение 14 контрольных показателей. 14 показателей перечислены ниже, а подробные метаданные для каждого из компонентов представлены в Интернете (<a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf\"> http://www.who.int/healthinfo/universal_health_coverage/UHC_Tracer_Indicators_Metadata.pdf</a>) и в Приложении 1. Следующие контрольные показатели сгруппированы в четыре широкие категории охвата услугами: </p>\n<p> <strong> <em> I. Репродуктивное здоровье, здоровье матери, новорожденного и ребенка </em> </strong> </p>\n<p>1. <strong> Планирование семьи </strong>: доля женщин репродуктивного возраста (15 - 49 лет), состоящих в браке или в консенсуальном союзе, которые удовлетворяют свои потребности в планировании семьи с помощью современных методов </p>\n<p> 2. <strong> Медицинская помощь при беременности и родах </strong>: доля женщин в возрасте 15–49 лет, родивших живых детей за определенный период времени, которые получали дородовую помощь четыре или более раз </p>\n<p> 3. <strong> Иммунизация детей </strong>: доля младенцев, получивших три дозы вакцины против дифтерии, столбняка и коклюша </p>\n<p> 4. <strong> Детское лечение </strong>: доля детей в возрасте до 5 лет с подозрением на пневмонию (кашель и затрудненное дыхание, НЕ из-за проблем с грудной клеткой и заложенного носа) в течение двух недель, предшествующих обследованию, направленных в соответствующее медицинское учреждение или к медработнику </p>\n<p><strong><em>II. Инфекционные болезни </em> </strong> </p>\n<p> 5. <strong> Туберкулез </strong>: доля выявленных и успешно вылеченных случаев туберкулеза </p>\n<p> 6. <strong> ВИЧ / СПИД </strong>: доля людей, живущих с ВИЧ, в настоящее время получающих антиретровирусную терапию </p>\n<p> 7. <strong> Малярия </strong>: доля лиц в эндемичных по малярии районах, которые прошлой ночью спали под обработанной инсектицидом сеткой [только для стран с высокой заболеваемостью малярией].</p>\n<p>8. <strong> Водоснабжение и санитария </strong>: доля домохозяйств, использующих хотя бы основные средства санитарии </p>\n<p><strong><em>III. Неинфекционные заболевания </em> </strong> </p>\n<p> 9. <strong> Гипертония </strong>: стандартизованная по возрасту распространенность не повышенного артериального давления (систолическое артериальное давление <140 мм рт. ст. или диастолическое артериальное давление <90 мм рт. ст.) среди взрослых в возрасте 18 лет и старше </p>\n<p> 10. <strong> Диабет </strong>: стандартизованное по возрасту среднее значение уровня глюкозы в плазме натощак (ммоль / л) для взрослых в возрасте 18 лет и старше </p>\n<p> 11. <strong> Табакокурение </strong>: стандартизованный по возрасту показатель распространенности среди взрослых > = 15 лет, не куривших табак за последние 30 дней (показатель 3.a.1 ЦУР, метаданные доступны <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0a-01.pdf\">здесь</a>) </p>\n<p><strong><em> IV. Объем услуг и доступ к услугам </em> </strong> </p>\n<p> 12. <strong> Доступ в больницу </strong>: количество больничных коек на душу населения, относительно максимального порогового значения 18 больничных коек на 10 000 населения </p>\n<p> 13. <strong> Работники здравоохранения </strong>: специалисты-медики (врачи, психиатры и хирурги) на душу населения относительно максимальных пороговых значений для каждой группы специалистов (частичное совпадение с показателем 3.c.1 ЦУР, см. метаданные <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0C-01.pdf\">здесь</a>) </p>\n<p> 14. <strong> Безопасность здоровья </strong>: индекс основных возможностей, изложенных в Международных медико-санитарных правилах (ММСП), который представляет собой среднюю долю атрибутов 13 основных возможностей, которые были достигнуты (показатель 3.d.1 ЦУР, см. метаданные <a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0D-01.pdf\">здесь</a>) </p><h1> Источники данных </h1>\n<h2> Описание: </h2>\n<p>Многие контрольные показатели охвата услугами здравоохранения определяются при проведении обследований домохозяйств. Однако для определенных показателей используются административные данные, объектные данные, обследования объектов и системы дозорного санэпиднаблюдения. Источники данных, лежащие в основе каждого из 14 показателей, более подробно описаны в Приложении 1. </p>\n<p> Что касается значений, используемых для вычисления индекса, значения берутся из существующих опубликованных источников. Сюда входят собранные наборы данных и оценки различных агентств ООН. Это кратко изложено в приведенной выше ссылке.</p><h2> Процесс сбора: </h2>\n<p>Механизмы сбора страновых данных различаются по всем 14 контрольным показателям, однако во многих случаях агентство ООН или межведомственная группа подбирают и анализируют соответствующие национальные источники данных, а затем проводят официальные страновые консультации с правительственными органами стран для проверки или получения сопоставимых оценок по стране. Что касается индекса охвата услугами ВОУЗ, то после сопоставления существующей информации по 14 показателям Всемирная организация здравоохранения проводит страновые консультации с назначенными координаторами от национальных правительственных органов для анализа исходных данных и расчета индекса. ВОЗ не предпринимает новых оценочных мероприятий для получения значений контрольных показателей для индекса охвата услугами; скорее, индекс разработан для использования существующих и хорошо зарекомендовавших себя рядов данных по показателям с целью снижения бремени отчетности. </p><h1> Календарь </h1>\n<h2> Сбор данных: </h2>\n<p> Данные по контрольным показателям собираются с различной периодичностью от ежегодного до 5-летнего цикла. Например, страновые данные по иммунизации и лечению от ВИЧ представляются ежегодно, тогда как обследования домашних хозяйств для сбора информации о лечении детей могут проводиться каждые 3-5 лет в зависимости от страны. Более подробная информация об отдельных контрольных показателях представлена в Приложении 1.</p><h2> Выпуск данных: </h2>\n<p> Первый выпуск базовых значений индекса охвата услугами ВОУЗ состоялся в декабре 2017 года. Ожидается, что обновленные данные будут выпущены в сентябре 2019 года. </p><h1> Поставщики данных </h1>\n<p> В большинстве случаев министерства здравоохранения и национальные статистические управления курируют сбор данных и представление отчетности по показателям охвата услугами здравоохранения. </p><h1> Составители данных </h1>\n<p> Всемирная организация здравоохранения, используя материалы других международных агентств. </p><h2> Обоснование: </h2>\n<p> Задача 3.8 определяется как «Обеспечить всеобщий охват услугами здравоохранения, в том числе защиту от финансовых рисков, доступ к качественным основным медико-санитарным услугам и доступ к безопасным, эффективным, качественным и недорогим основным лекарственным средствам и вакцинам для всех». Основное внимание направлено на то, чтобы все люди и сообщества получали качественные медицинские услуги, в которых они нуждаются (включая лекарства и другие товары для здоровья), без финансовых затруднений. Для мониторинга задачи 3.8 в рамках ЦУР были выбраны два показателя. Показатель 3.8.1 служит для отражения охвата услугами здравоохранения, а показатель 3.8.2 фокусируется на расходах на здравоохранение по отношению к бюджету домохозяйства для выявления финансовых трудностей, вызванных прямыми платежами за медицинское обслуживание. Взятые вместе, показатели 3.8.1 и 3.8.2 предназначены для отражения параметров охвата услугами и финансовой защищенности, относящиеся, соответственно, к задаче 3.8. Эти два показателя всегда следует контролировать совместно.</p>\n<p> Страны предоставляют множество основных услуг по охране, укреплению, профилактике, лечению и уходу за здоровьем. Показатели охвата услугами \"определенные с помощью наличия лиц, получающие необходимые им услуги\" - это лучший способ отслеживать прогресс в предоставлении услуг в рамках всеобщего охвата услугами здравоохранения (ВОУЗ). Поскольку одного показателя услуг здравоохранения недостаточно для мониторинга ВОУЗ, индекс строится из 14 показателей, отобранных на основе эпидемиологических и статистических критериев. Это включает несколько показателей, которые уже отражены в других задачах ЦУР, что позволяет минимизировать бремя сбора данных и представления отчетности. Индекс отображается на безразмерной шкале от 0 до 100, где 100 является оптимальным значением. </p><h2> Комментарии и ограничения: </h2>\n<p>Эти контрольные показатели предназначены для отражения охвата услугами, а не для представления полного или исчерпывающего списка медицинских услуг и лечебных процедур, необходимых для всеобщего охвата услугами здравоохранения. Было выбрано 14 контрольных показателей, поскольку они являются общепризнанными, с доступными данными, широко представляемыми странами (или ожидается, что они вскоре станут широко доступными). Следовательно, индекс может быть вычислен с использованием существующих источников данных и не требует инициирования новых усилий по сбору данных исключительно для того, чтобы сформировать индекс.</p><h1>Методология</h1>\n<p><strong>Метод расчета:</strong></p>\n<p>Индекс рассчитывается с использованием средних геометрических значений на основе методов, используемых для расчета индекса человеческого развития. Для расчета показателя 3.8.1 необходимо сначала подготовить 14 контрольных показателей, чтобы их можно было объединить в индекс, а затем вычислить индекс на основе этих значений. </p>\n<p> Все 14 контрольных показателей сначала помещаются на одну и ту же шкалу, где 0 - наименьшее значение, а 100 - оптимальное значение. Для большинства показателей эта шкала является естественной шкалой измерения, например, доля иммунизированных младенцев колеблется от 0 до 100 процентов. Однако для некоторых показателей требуется дополнительное изменение масштаба для получения соответствующих значений от 0 до 100, как показано ниже:</p>\n<ul>\n  <li>Изменение масштаба на основе ненулевого минимума для получения более точного разрешения (это \"растягивает\" распределение по странам): распространенность не повышенного артериального давления и распространенность не курения табака перемасштабируются с использованием минимального значения 50%.<ul>\n      <li>перемасштабированное значение = (X-50)/(100-50)*100</li>\n    </ul>\n  </li>\n  <li>Изменение масштаба для постоянно проводимого измерения: среднее значение глюкозы в плазме натощак, которое является постоянно измеряемым показателем (единицы ммоль / л), преобразуется в шкалу от 0 до 100 с использованием минимального теоретического биологического риска (5,1 ммоль / л) и наблюдаемого максимума по странам (7,1 ммоль / л).<ul>\n      <li>перемасштабированное значение = (7.1 - начальное значение)/(7.1-5.1)*100</li>\n    </ul>\n  </li>\n  <li>Максимальные пороговые значения для показателей доли: плотность больничных коек и плотность кадров здравоохранения ограничены максимальными пороговыми значениями, а значения выше этого порога остаются неизменными на уровне 100. Эти пороговые значения основаны на минимальных значениях, наблюдаемых в странах ОЭСР.<ul>\n      <li>перемасштабированное количество больничных коек на 10,000 населения = минимум 100, начальное значение / 18*100)</li>\n      <li>перемасштабированное количество врачей на 1,000 населения = минимум (100, начальное значение / 0.9*100)</li>\n      <li>перемасштабированное количество психиатров на 100,000 населения = минимум (100, начальное значение / 1*100)</li>\n      <li>перемасштабированное количество хирургов на 100,000 населения = минимум (100, начальное значение / 14*100)</li>\n    </ul>\n  </li>\n</ul>\n<p>После того, как все значения контрольных показателей располагаются на шкале от 0 до 100, вычисляются средние геометрические значения в каждой из четырех областей медицинского обслуживания, а затем для этих четырех значений берется среднее геометрическое значение. Если значение контрольного показателя оказывается равным нулю, оно устанавливается на 1 (из 100) перед вычислением среднего геометрического значения. Следующая диаграмма иллюстрирует расчеты.</p>\n<p><img src=\"data:image/png;base64,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\"></p>\n<p>Обратите внимание, что в странах с низкой заболеваемость малярией контрольный показатель по использованию обработанных инсектицидами сеток исключается из расчета.</p><h2>Обработка отсутствующих значений: </h2>\n<ul>\n  <li> <strong> <em> На страновом уровне: </em> </strong> </li>\n</ul>\n<p> Отправной точкой для расчета индекса является сбор существующей информации по каждому контрольному показателю. Во многих случаях это включает использование временных рядов по странам, которые были созданы или сопоставлены агентствами ООН в процессе консультаций с правительственными органами страны (например, охват иммунизацией, доступ к санитарии, охват лечением ВИЧ и т. д.). Некоторые из этих опубликованных временных рядов включают математическое моделирование для согласования нескольких источников данных или вменения отсутствующих значений и эти детали кратко изложены в Приложении 1. </p>\n<p> После сбора этих исходных данных по некоторым показателям по-прежнему отсутствуют значения для некоторых стран-лет. Для расчета индекса охвата услугами ВОУЗ требуется иметь значения каждого контрольного показателя для страны, поэтому для заполнения этих пробелов в данных необходимо проделать некоторое условное исчисление. Текущий подход включает простой алгоритм вменения. По каждому показателю: </p>\n<ul>\n  <li>\n    <ul>\n      <li> Если в стране отсутствуют значения в промежутке между двумя годами, по которым имеются данные, используется метод линейной интерполяции для заполнения отсутствующих значений в промежуточные годы. </li>\n       <li> Если в стране есть исторические ряды с годовыми данными, но нет данных текущего года, используется метод постоянной экстраполяции для заполнения недостающих значений текущего года. </li>\n       <li> Если в стране отсутствуют значения, значение вменяется. Для данных по обращению за помощью при пневмонии и плотности количества хирургов подходит метод регрессии для вменения пропущенных значений (подробности см. в Приложении 1). Для всех других показателей рассчитывается пространственная медиана для вменения пропущенных значений. Регионы основаны на географических регионах Всемирного банка с отдельной группой стран с традиционно высоким уровнем дохода. <sup> <a href=\"#footnote-1\" id=\"footnote-ref-1\"> [1] </a> </sup> </li>\n    </ul>\n  </li>\n</ul>\n<p>Принимая во внимание сроки и распределение различных обследований состояния здоровья и других механизмов сбора данных страны не собирают и не отчитываются по всем 14 контрольным показателям охвата услугами здравоохранения на ежегодной основе. Кроме того, мониторинг на страновом уровне лучше всего проводить через более длительные интервалы времени, например, каждые 5 лет, чтобы обеспечить сбор новых данных по показателям. Следовательно, вместе со значением индекса следует указывать до какой степени использовалось вменение для восполнения отсутствующей информации. </p>\n<ul>\n  <li> <strong> <em> На региональном и глобальном уровнях: </em> </strong> </li>\n</ul>\n<p> Все необходимые условные расчеты производятся на страновом уровне. Эти страновые значения затем можно использовать для вычисления региональных и глобальных значений. </p><div class=\"footnotes\"><div><sup class=\"footnote-number\" id=\"footnote-1\">1</sup><p> Аргентина, Австралия, Австрия, Бельгия, Бруней-Даруссалам, Канада, Чили, Кипр, Чехия, Дания, Эстония, Финляндия, Франция, Германия, Греция, Исландия, Ирландия, Израиль, Италия, Япония, Люксембург, Мальта, Нидерланды, Новая Зеландия, Норвегия, Польша, Португалия, Республика Корея, Сингапур, Словакия, Словения, Испания, Швеция, Швейцария, Великобритания, Соединенные Штаты Америки, Уругвай.<a href=\"#footnote-ref-1\">&#x2191;</a></p></div></div><h2> Региональные агрегаты: </h2>\n<p> Региональные и глобальные агрегированные показатели рассчитываются с использованием данных по численности населения страны для вычисления средневзвешенного значения индекса для конкретной страны. Это оправдано тем, что показатель всеобщего охвата услугами здравоохранения (ВОУЗ) является достоянием стран, а индекс основных услуг является суммарным показателем доступа к основным услугам для населения каждой страны. </p><h1> Доступность данных </h1>\n<h2> Описание: </h2>\n<p> Обобщение доступности данных для индекса охвата услугами ВОУЗ произвести непросто, поскольку для 14 контрольных показателей используются разные источники данных. Кроме того, по многим показателям были произведены сопоставимые оценки, во многих случаях с использованием различных типов источников базовых данных для формирования оценок, а также с использованием прогнозов для вменения недостающих значений. Основываясь на источниках базовых данных для каждого контрольного показателя (т.е. без учета оценок и прогнозов), средняя доля показателей, используемых для расчета индекса с базовыми данными, доступными с 2010 года, составляет около 70% по странам во всем мире.</p>\n<h2> Временные ряды: </h2>\n<p> В конце 2017 года было опубликовано базовое значение индекса охвата услугами ВОУЗ за 2015 год по 183 странам. В рамках этого процесса были собраны исходные данные, начиная с 2000 года. В 2019 году ожидается публикация временных рядов с 2000 по 2017 годы. </p>\n<h2> Дезагрегирование: </h2>\n<p>Равенство занимает центральное место в определении ВОУЗ, и поэтому индекс охвата услугами ВОУЗ следует использовать для обмена информацией о неравенстве в охвате услугами в странах. Это можно сделать, представив индекс отдельно для населения страны и малообеспеченных слоев населения, чтобы выявить различия между ними. </p>\n<p> Для стран географическое положение, вероятно, является наиболее подходящим параметром для субнациональной дезагрегации на основе средних уровней охвата, рассчитанных с использованием существующих источников данных. Для этого индекс ВОУЗ может быть рассчитан отдельно, например, по провинциям, городам и сельской местности, что позволит проводить сравнения охвата услугами на субнациональном уровне. В настоящее время наиболее доступные данные для дезагрегирования по другим параметрам неравенства, таким как благосостояние домохозяйств, относятся к показателям охвата в категории услуг в области репродуктивного здоровья, здоровья матерей, новорожденных и детей. Неравенство, наблюдаемое в этой сфере, можно использовать в качестве косвенного показателя для понимания различий в охвате услугами по ключевым параметрам неравенства. Этот подход следует заменить полным дезагрегированием всех 14 контрольных показателей, как только для этого станут доступны данные.</p><h2> Источники расхождений: </h2>\n<p> Индекс охвата услугами основан на существующих общедоступных данных и оценках контрольных показателей. Эти цифры уже прошли процесс страновых консультаций (например, по охвату иммунизацией) или взяты непосредственно из данных, представленных странами. </p><h1>Ссылки</h1>\n<h2><strong>URL: </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<h2><strong>Ссылки: </strong></h2>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2017/en/</a></p>\n<p><a href=\"http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf\">http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30472-2.pdf</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/en/\">http://www.who.int/healthinfo/universal_health_coverage/en/</a></p>\n<p>По истории развития методов см.:</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1\">http://www.who.int/healthinfo/universal_health_coverage/UHC_WHS2016_TechnicalNote_May2016.pdf?ua=1</a> (заменено этим документом)</p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/</a></p>\n<p><a href=\"http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/\">http://www.who.int/healthinfo/universal_health_coverage/report/2014/en/</a></p>\n<p><a href=\"http://collections.plos.org/uhc2014\">http://collections.plos.org/uhc2014</a></p>\n<h1>Приложение 1. Метаданные для контрольных показателей, используемых для оценки охвата основными медицинскими услугами для мониторинга показателя 3.8.1 ЦУР. </h1>\n<p> Любые комментарии или запросы направляйте по адресу: <a href=\"mailto:uhc_stats@who.int\">uhc_stats@who.int</a></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Планирование семьи</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля женщин репродуктивного возраста (15 - 49 лет), состоящих в браке или в консенсуальном союзе, которые удовлетворяют свои потребности в планировании семьи с помощью современных методов</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество замужних или состоящих в консенсуальном союзе женщин в возрасте 15-49 лет, пользующихся современными методами</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общее количество замужних или состоящих в консенсуальном союзе женщин в возрасте 15-49 лет, нуждающихся в планировании семьи</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования состояния здоровья населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</td>\n      <td>\n        <p>Обследования домашних хозяйств включают ряд вопросов для оценки уровня использования современных противозачаточных средств и спроса на услуги по планированию семьи. Общая потребность в планировании семьи определяется как сумма количества женщин репродуктивного возраста (15 - 49 лет), которые состоят в браке или в союзе и которые в настоящее время используют или чей сексуальный партнер в настоящее время использует хотя бы один метод контрацепции, и неудовлетворенных потребностей в планировании семьи. Неудовлетворенная потребность в планировании семьи - это доля женщин репродуктивного возраста (15 - 49 лет), состоящих в браке или консенсуальном союзе, имеющих способность к оплодотворению и сексуально активных, но не использующих какие-либо методы контрацепции (современные или традиционные), и заявляющих, что не хотят больше детей или хотят отложить рождение следующего ребенка как минимум на два года. Сюда включены:</p>\n        все беременные женщины (замужние или состоящие в консенсуальном союзе), чья беременность была нежелательной или несвоевременной на момент зачатия; </p>\n        <p> все женщины с послеродовой аменореей (замужние или состоящие консенсуальном союзе), которые не используют планирование семьи и чьи последние роды были нежелательными или несвоевременными; </p>\n        <p> все плодовитые женщины (замужние или состоящие в консенсуальном союзе), которые не беременны и не страдают послеродовой аменореей, и которые либо не хотят больше детей (хотят ограничить размер семьи), либо хотят отложить рождение ребенка на, по крайней мере, два года или не знают, когда захотят и захотят ли они еще одного ребенка (хотят иметь промежутки между родами), но не используют никаких методов контрацепции. </p>\n        <p> Современные методы включают женскую и мужскую стерилизацию, внутриматочные средства (ВМС), имплант, инъекции, оральные противозачаточные таблетки, мужские и женские презервативы, методы влагалищного барьера (включая диафрагму, цервикальный колпачок и спермицидную пену, желе, крем и губку), метод лактационной аменореи (МЛА), экстренную контрацепцию и другие современные методы, которые отдельно не включаются в отчет.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</td>\n      <td>\n        <p>Отдел народонаселения Организации Объединенных Наций составляет систематические и всеобъемлющие серии ежегодных оценок и прогнозов доли замужних женщин или женщин, состоящих в консенсуальном союзе, чьи потребности по планированию семьи удовлетворяются. Байесовская иерархическая модель в сочетании с данными по конкретной стране используется для создания оценок, прогнозов и оценок неопределенности на основе данных обследований. Модель учитывает различия в источниках данных, выборочной совокупности и методах контрацепции. </p>\n         <p> Подробнее см. здесь: <a href=\"http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml\">http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td></td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Беременность и помощь при родах</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля женщин в возрасте 15-49 лет, родивших живого ребенка в определенный период времени, которые получали дородовую помощь четыре или более раз </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество женщин в возрасте 15-49 лет, родивших живого ребенка в определенный период времени, которые получали дородовую помощь четыре или более раз</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общее количество женщин в возрасте 15-49 лет, родивших живого ребенка в тот же период времени.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования домашних хозяйств и стандартные информационные системы учреждений</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Данные по четырем или более посещениям с целью дородового наблюдения основаны на вопросах, в которых спрашивают, проверялось ли и сколько раз здоровье женщины во время беременности. Обследования домашних хозяйств, на основе которых может рассчитываться этот показатель, включают DHS, MICS, RHS и другие обследования, основанные на аналогичных методологиях. Системы отчетности об услугах / учреждений могут использоваться там, где охват высок, обычно в странах с более высоким уровнем дохода.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>ВОЗ ведет базу данных по охвату дородовой помощью: <a href=\"http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4\">http://apps.who.int/gho/data/node.main.ANTENATALCARECOVERAGE4</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>В идеале этот показатель следует заменить более полным показателем ухода во время беременности и родов, например, долей женщин, у которых квалифицированный медработник присутствует при родах или в родильных домах. Проблема оценки квалифицированного родовспоможения состоит в том, чтобы определить, какие медицинские работники являются «квалифицированными».</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<p><br></p>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Иммунизация детей</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля младенцев, получивших три дозы вакцины против дифтерии, столбняка и коклюша</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Дети до 1 года, получившие три дозы вакцины против дифтерии, столбняка и коклюша.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Все дети в возрасте до 1 года</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования домашних хозяйств и информационные системы учреждений</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Что касается данных обследования, прививочный статус детей в возрасте от 12 до 23 месяцев собирается из детских медицинских карт или, если карт нет, из отзыва их опекуна. Из административных данных извлекается информация об общем количестве доз, введенных целевой группе населения.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Совместно ВОЗ и ЮНИСЕФ получают оценки охвата введенных доз вакцины против дифтерии, столбняка и коклюша (АКДС3) на основе данных, официально представленных в ВОЗ и ЮНИСЕФ государствами-членами, а также данных, представленных в опубликованных изданиях и \"серой\" литературе. Они также консультируются с местными экспертами - в первую очередь с национальными управляющими РПИ и сотрудниками региональных бюро ВОЗ - для получения дополнительной информации о деятельности конкретных местных служб иммунизации. Основываясь на имеющихся данных, учете возможных предубеждений и вкладе местных экспертов, ВОЗ / ЮНИСЕФ определяют наиболее вероятный истинный уровень охвата иммунизацией. </p>\n         <p> Подробнее см. здесь: \n        <a href=\"http://www.who.int/bulletin/volumes/87/7/08-053819/en/\">http://www.who.int/bulletin/volumes/87/7/08-053819/en/</a></p>\n        <p><a href=\"http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html\">http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Национальные графики вакцинации в разных странах неодинаковы. Учитывая это, одним из вариантов мониторинга полной иммунизации детей является мониторинг доли детей, получающих вакцины, включенных в национальный календарь их страны. Второй вариант, который может быть более сопоставимым по странам и по времени, - это мониторинг охвата АКДС3 в качестве показателя полной иммунизации детей. Вакцина против дифтерии, столбняка и коклюша часто включает другие вакцины, например, против гепатита B и гемофильной инфекции типа B, и является разумным отражением того, до какой степени создана надежная платформа вакцинирования в стране. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Лечение детей (обращение за помощью при симптомах пневмонии)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля детей в возрасте до 5 лет с подозрением на пневмонию (кашель и затрудненное дыхание, НЕ из-за проблем в грудной клетке и заложенного носа) в течение двух недель, предшествующих обследованию, доставленных в соответствующее медицинское учреждение или к медработнику.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество детей с подозрением на пневмонию в течение двух недель, предшествующих обследованию, доставленных к соответствующему медработнику.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Количество детей с подозрением на пневмонию за две недели, предшествующие обследованию.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования домохозяйств</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>На совещании ЮНИСЕФ / ВОЗ по показателям выживаемости детей, состоявшемся в Нью-Йорке 17-18 июня 2004 года, было рекомендовано описывать острые респираторные инфекции (ОРИ) как «предполагаемую пневмонию», чтобы лучше отразить вероятную причину и рекомендуемые методы лечения. Определение предполагаемой пневмонии, используемое в обследованиях демографических характеристик и состояния здоровья (DHS) и в кластерных обследованиях по многим показателям (MICS), было выбрано группой и основано на восприятии матерями ребенка, который кашляет, дышит чаще, чем обычно, с короткими, частыми вдохами или затрудненным дыханием, за исключением детей, у которых был только заложен нос. Определение \"соответствующего\" медицинского работника варьируется в зависимости от страны. </p>\n         <p> ВОЗ ведет базу данных наблюдений на страновом уровне по результатам обследований домашних хозяйств, доступ к которой можно получить здесь: <a href=\"http://apps.who.int/gho/data/node.main.38?lang=en\">http://apps.who.int/gho/data/node.main.38?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>В настоящее время нет сопоставимых на международном уровне оценок по этому показателю.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Этот показатель обычно не рассчитывается в странах с более высокими доходами и хорошо развитыми системами здравоохранения. </p>\n         <p> Для стран, в которых нет данных наблюдений, охват оценивался с помощью метода регрессии, который прогнозирует охват обращений за помощью по поводу симптомов пневмонии (по логит-шкале), полученной из базы данных ВОЗ, описанной выше, как функции логарифма расчетного коэффициент смертности детей от пневмонии в возрасте до пяти лет, который можно найти здесь: <a href=\"https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html\">https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html</a></p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Лечение туберкулеза</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля случаев заболевания туберкулезом, которые были выявлены и успешно вылечены в конкретном году</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество новых случаев и рецидивов, выявленных за год и успешно вылеченных</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Количество новых случаев и рецидивов в том же году</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Информационные системы учреждений, системы санэпиднадзора, обследования состояния здоровья населения с диагностическим тестированием на ТБ, регистр ТБ и соответствующая система ежеквартальной отчетности (или электронные регистры ТБ)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Этот показатель требует трех основных входных параметров: </p>\n         <p> (1) Число новых и рецидивных случаев ТБ, диагностированных и вылеченных в рамках национальных программ борьбы с ТБ и сообщенных в ВОЗ в течение данного года. </p>\n         <p> (2) Число случаев туберкулеза за тот же год обычно оценивается ВОЗ. </p>\n         <p> (3) Доля случаев ТБ, успешно вылеченных (вылеченных плюс лечение завершено ) среди случаев ТБ, о которых было сообщено национальным органам здравоохранения.</p>\n        <p>Заключительный показатель = (1)/(2) x (3)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Оценки заболеваемости ТБ производятся в рамках консультативно-аналитического процесса под руководством ВОЗ и публикуются ежегодно. Эти оценки основаны на ежегодных уведомлениях о случаях заболевания, оценке качества и охвата данных уведомлений о ТБ, национальных обследованиях распространенности ТБ и информации из систем регистрации смертей (естественного движения населения). Оценки заболеваемости для каждой страны производятся с использованием одного или нескольких из следующих подходов в зависимости от имеющихся данных: </p>\n         <p> 1. заболеваемость = уведомления о случаях / приблизительная доля выявленных случаев; </p>\n         <p> 2. заболеваемость = распространенность / продолжительность состояния; </p>\n         <p> 3. заболеваемость = количество смертей / доля умерших от впервые выявленных случаев. </p>\n         <p> Эти оценки заболеваемости туберкулезом сочетаются с данными по стране по количеству выявленных и вылеченных случаев, а также по доле успешно вылеченных случаев, как описано выше.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Чтобы рассчитать показатель с использованием оценок ВОЗ, можно получить доступ к необходимым файлам здесь: <a href=\"http://www.who.int/tb/country/data/download/en/\">http://www.who.int/tb/country/data/download/en/</a>, and compute the indicator as = c_cdr x c_new_tsr</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Лечение ВИЧ</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля людей, живущих с ВИЧ, в настоящее время получающих антиретровирусную терапию (АРТ)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество взрослых и детей, получающих АРТ на конец отчетного периода</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Количество взрослых и детей, живущих с ВИЧ, за тот же период</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Системы отчетности учреждений, участки дозорного санэпиднадзора, обследования населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Числитель: числитель можно получить, подсчитав количество взрослых и детей, получавших комбинированную антиретровирусную терапию в конце отчетного периода. Данные могут быть собраны из регистров АРТ на базе учреждений или систем управления поставками лекарств. Затем они подсчитываются и передаются в ежемесячные или квартальные отчеты, которые затем могут быть агрегированы для получения общенациональных итогов. Пациенты, получающие АРТ в частном и государственном секторах, должны быть включены в числитель. </p>\n         <p> Знаменатель: данные по количеству людей с ВИЧ-инфекцией могут поступать из обследований населения или, как это принято в странах Африки к югу от Сахары, из систем санэпиднадзора, основанных при женских консультациях.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Оценки охвата антиретровирусным лечением людей, живущих с ВИЧ в 2000-2018 годах, получены в рамках оценочного раунда исследования ЮНЭЙДС в 2019 году.</p>\n         <p> Для оценки количества людей, живущих с ВИЧ, в динамике по времени в странах с высоким уровнем заболеваемости ВИЧ, ЮНЭЙДС в сотрудничестве со странами использует эпидемическую модель (Spectrum), которая объединяет данные санэпиднадзора по распространенности с текущим количеством пациентов, получающих АРТ, и предположениями о естественной истории прогрессирования ВИЧ-инфекции. </p>\n         <p> Поскольку теперь АРТ рекомендуется всем людям, живущим с ВИЧ, мониторинг охвата АРТ менее сложен, чем раньше, когда право на АРТ имели только люди с определенным уровнем тяжести заболевания. </p>\n        <p>Оценки охвата АРТ можно найти здесь: <a href=\"http://aidsinfo.unaids.org/\">http://aidsinfo.org</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Сопоставимые оценки охвата АРТ в странах с высоким уровнем доходов, в частности временные тенденции, не всегда доступны.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Профилактика малярии</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля населения в эндемичных по малярии районах, которые прошлой ночью спали под обработанными инсектицидами противомоскитными сетками.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество населения в эндемичных по малярии районах, которые спят под обработанными инсектицидами противомоскитными сетками</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общее количество населения в эндемичных по малярии районах.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Данные по доступу домашних хозяйств к обработанным инсектицидами противомоскитным сеткам (ОИС) и их использовании поступают из национальных репрезентативных обследований домашних хозяйств, таких как обследования демографических характеристик и состояния здоровья, кластерные обследования по многим показателям и обследования показателей малярии. Данные по количеству ОИС, доставленных производителями в страны, собираются Milliner Global Associates, а данные по количеству ОИС, распределенных внутри стран, представляются Национальными программами борьбы с малярией.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Многие недавние национальные обследования отчитываются о количестве ОИС, наблюдаемых в каждом домохозяйстве-респонденте. Коэффициенты владения могут быть преобразованы в долю людей, спящих под ОИС, с использованием линейной зависимости между доступом и использованием, которая была получена в результате 62 обследований, в которых собирается информация по обоим показателям. </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Математические модели могут использоваться для объединения данных обследований домашних хозяйств по доступу и использованию с информацией о доставке ОИС от производителей и о распределении ОИС национальными программами по борьбе с малярией для получения ежегодных оценок охвата ОИС. ВОЗ использует этот подход в сотрудничестве с проектом «Атлас малярии». Подробные методологические данные можно найти в Приложении к Всемирному докладу по малярии за 2015 год:<a href=\"http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/\">http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/</a>.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>ВОЗ производит сопоставимые оценки охвата ОИС для 40 стран с высоким уровнем заболеваемости. Для других стран охват ОИС не включается в индекс охвата услугами ВОУЗ из-за ограничений данных. </p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Водоснабжение и санитария</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Доля домохозяйств, пользующихся хотя бы основными средствами санитарии</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Население, проживающее в домохозяйстве, где имеется: смыв или туалет с ручным смывом, септическая яма или уборная с выгребной ямой; вентилируемая уборная с выгребной ямой; выгребная яма с плитой; или компостный туалет.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общая численность населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования домашних хозяйств и переписи населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Ответы на уровне домохозяйства, взвешенные на размер домохозяйства, используются для расчета охвата населения.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Совместная программа мониторинга ВОЗ / ЮНИСЕФ регулярно производит оценки охвата, по крайней мере, базовых средств санитарии для мониторинга ЦРТ. После создания базы данных доступных источников данных для каждой страны простые линейные регрессии подгоняются к рядам страновых данных, чтобы получить внутривыборочную оценку, а также произвести двухлетнюю экстраполяцию вне последнего доступного элемента данных, после чего охват сохраняется постоянным в течение 4 лет, а затем считается отсутствующим. Это делается отдельно для городских и сельских регионов, а затем они объединяются для получения оценок национального охвата. Подробную информацию о методологии и самые последние оценки можно найти здесь.: <a href=\"http://www.wssinfo.org/\">http://www.wssinfo.org</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Показатель ЦУР в области санитарии (ЦУР 6.2.1) представляет собой расширенную версию показателя ЦРТ, включающую качество санитарного оборудования. Это не используется для мониторинга ВОУЗ из-за более низкой доступности данных. Можно также рассмотреть совместный показатель, определяющий долю домохозяйств, имеющих доступ как к безопасной воде, так и к санитарным услугам.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Профилактика сердечно-сосудистых заболеваний</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Стандартизованная по возрасту распространенность нормального артериального давления среди взрослых в возрасте 18+, независимо от статуса лечения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество взрослых в возрасте 18 лет и старше с систолическим артериальным давлением <140 мм рт. ст. и диастолическим артериальным давлением <90 мм рт. ст. (независимо от статуса лечения)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Количество взрослых в возрасте 18 лет и старше</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования населения и системы санэпиднадзора</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Используются источники данных, фиксирующие измеренное артериальное давление (данные самостоятельных измерений исключены). Если у каждого участника измеряется несколько значений артериального давления, первое показание отбрасывается, а остальные значения усредняются.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Для получения сопоставимых национальных оценок данные наблюдений за распространенностью, определенные в виде альтернативных пороговых значений САД и / или ДАД, преобразуются в распространенность повышенного артериального давления, определяемого как систолическое артериальное давление > = 140 мм рт. ст. или диастолическое артериальное давление > = 90 мм. рт. ст. с использованием уравнений регрессии. Затем для этих данных подбирается Байесовская иерархическая модель для расчета распространенности по возрасту, полу, году и стране, которая учитывает национальные и субнациональные источники данных, городские и сельские источники данных и учитывает различия в распространенности по возрасту и полу. Стандартизированные по возрасту оценки затем производятся путем применения приблизительных оценок к Стандарту населения ВОЗ. Подробная информация о статистических методах находится здесь: <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext</a></p>\n        <p>ВОЗ и Сотрудничество по факторам риска неинфекционных заболеваний - НИЗ (NCD-RisC) подготовили сопоставимые оценки для этого показателя вплоть до 2015 года, которые доступны здесь: </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en\">http://apps.who.int/gho/data/node.main.A875STANDARD?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Оценки распространенности преобразуются в распространенность нормального артериального давления для включения в индекс ВОУЗ, так что значение 100% является оптимальной целью. Это вычисляется как: распространенность нормального артериального давления = 1 - распространенность повышенного артериального давления. Вышеуказанные оценки сделаны отдельно для мужчин и женщин; для показателя ВОУЗ вычисляется простое среднее значение для мужчин и женщин </p>\n         <p> Нормальное артериальное давление - это сумма доли лиц, не страдающих гипертонией, и доли лиц, у которых гипертония контролируется лекарствами. Отсутствие гипертонии является результатом профилактических мер, направленных на пропаганду физической активности и здорового питания, а также других факторов. Гипертония, контролируемая лекарствами, - это результат эффективного лечения. Таким образом, этот показатель является показателем как эффективного укрепления здоровья, так и эффективных медицинских услуг.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Лечение диабета</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Стандартизированный по возрасту средний уровень глюкозы в плазме натощак для взрослых в возрасте 18 лет и старше</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования населения и системы санэпиднадзора</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Уровни глюкозы в плазме натощак (ГПН) определяют путем взятия пробы крови участников, голодавших не менее 8 часов. Другие связанные биомаркеры, такие как гемоглобин A1c (HbA1c), использовались для расчета оценок (см. ниже).</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Для получения сопоставимых национальных оценок все данные наблюдений, основанные на среднем значении ГПН, пероральном тесте на толерантность к глюкозе (OGTT), HbA1c или ее комбинациям, преобразуются в среднее значение ГПН. Затем к этим данным подбирается Байесовская иерархическая модель для расчета распространенности по возрасту, полу, году и стране, которая учитывает национальные и субнациональные источники данных, городские и сельские источники данных и учитывает различия в распространенности по возрасту и полу. Стандартизированные по возрасту оценки затем производятся путем применения приблизительных оценок к Стандарту населения ВОЗ. Подробности методологии можно найти здесь: <a href=\"https://www.who.int/diabetes/global-report/en/\">https://www.who.int/diabetes/global-report/en/</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>ГПН человека может быть низким из-за эффективного лечения сахароснижающими препаратами или из-за того, что человек не страдает диабетом в результате мероприятий по укреплению здоровья или других факторов, таких как генетика. Таким образом, среднее значение ГПН является показателем как эффективной пропаганды здорового питания и поведения, так и эффективного лечения диабета. </p>\n         <p> Вышеуказанные оценки сделаны отдельно для мужчин и женщин; для показателя ВОУЗ вычисляется простое среднее значение для мужчин и женщин.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Борьба против табакокурения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Стандартизованный по возрасту показатель распространенности среди взрослых > = 15 лет, не куривших табак в течение последних 30 дней </p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Взрослые от 15 лет и старше, не курившие табак в течение последних 30 дней</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Взрослые от 15 лет и старше</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследования домохозяйств</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>\"Текущее табакокурение\" включает сигареты, сигары, трубки или любые другие курительные табачные изделия, использованные за последние 30 дней. Данные собираются посредством самоотчетов в обследованиях.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>ВОЗ оценивает распространенность нынешнего табакокурения (некурящих) с помощью модели отрицательной биномиальной мета-регрессии, которая создает сопоставимые оценки путем корректировки различий в возрастных группах и определения показателей в национальных обследованиях, включенных в анализ. Эти оценки делаются отдельно для мужчин и женщин. Подробности методологии можно найти здесь:<a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental\">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/supplemental</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Распространенность отказа от табакокурения рассчитывается как 1 минус распространенность табакокурения</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Доступ к больнице</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Количество больничных коек на душу населения относительно максимального порогового значения 18 на 10 000 населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество больничных коек (не включая кровати для рожениц и родов)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общая численность населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Административные системы / Система отчетности медицинских учреждений</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Страновые административные системы используются для суммирования количества больничных коек, которое делится на общую предполагаемую численность населения и умножается на 10 000. </p>\n         <p> Региональные бюро ВОЗ и другие группы собирают информацию о плотности койко-мест в национальных больницах, включая следующие онлайн-ресурсы:</p>\n        <p><a href=\"https://rho.emro.who.int/rhodata/node.main.A36\">https://rho.emro.who.int/rhodata/node.main.A36</a></p>\n        <p>Региональная обсерватория ВОЗ AFRO: <a href=\"http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population\">http://www.aho.afro.who.int/en/data-statistics/hospital-beds-10-000-population</a></p>\n        <p>Европейская база данных ВОЗ \"Здоровье для всех\": <a href=\"https://gateway.euro.who.int/en/datasets%20european-health-for-all-database/\">https://gateway.euro.who.int/en/datasets european-health-for-all-database/</a></p>\n        <p>ОЭСР: <a href=\"https://data.oecd.org/healtheqt/hospital-beds.htm\">https://data.oecd.org/healtheqt/hospital-beds.htm</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>На основании имеющихся данных показатель рассчитывается относительно порогового значения 18 больничных коек на 10 000 населения. Этот порог ниже наблюдаемого минимума для стран ОЭСР с высоким уровнем дохода (с 2000 года), составляющего 20 на 10 000, и, как правило, соответствует уровню госпитализации около 5 на 100 в год. Этот показатель предназначен для определения низкого уровня пропускной способности больниц; используется максимальный порог, поскольку очень высокая плотность больничных коек не является необходимой для эффективного использования ресурсов. Показатель рассчитывается следующим образом с использованием данных по стране по плотности больничных коек (x), что дает значения от 0 до 100:</p>\n        <p>Страна с плотностью больничных коек x <18 на 10 000 в год, показатель = </p>\n        <p><em>x</em> /18*100. </p>\n        <p>Страна с плотностью больничных коек x> = 18 на 10 000 в год, показатель = 100.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Альтернативным показателем может быть частота госпитализаций по отношению к максимальному порогу. Однако этот показатель в настоящее время широко не представляется по регионам, особенно по африканскому региону. В странах, где доступны как больничные койки на душу населения, так и показатели госпитализации, они сильно взаимосвязаны.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Кадры здравоохранения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Количество специалистов здравоохранения (врачей, психиатров и хирургов) на душу населения относительно максимальных пороговых значений для каждой группы специалистов</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество врачей, психиатров и хирургов</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общая численность населения</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Национальная база данных или регистр медицинских работников, в идеале в сочетании с регулярной оценкой полноты с использованием данных переписи, регистров профессиональных ассоциаций или переписей учреждений.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Классификация медицинских работников основана на критериях профессионального образования и обучения, упорядочении медицинских профессий, а также деятельности и задачах рабочих мест, то есть на основе классификации ключевых переменных кадровых ресурсов в соответствии с общими характеристиками. Структура ВОЗ в значительной степени основана на последних пересмотрах международно стандартизированных систем классификации Международной организации труда (Международная стандартная классификация занятий), Организации Объединенных Наций по вопросам образования, науки и культуры (Международная стандартная классификация образования) и Статистического отдела Организации Объединенных Наций (Международная стандартная отраслевая классификация всех видов экономической деятельности). </p>\n        <p>Подробную методологическую информацию и данные можно найти здесь: <a href=\"http://www.who.int/hrh/statistics/hwfstats/en/\">http://www.who.int/hrh/statistics/hwfstats/en/</a></p>\n        <p>Данные взяты из следующих источников:</p>\n        <p>Врачи: <a href=\"http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en\">http://apps.who.int/gho/data/node.main.HWFGRP_0020?lang=en</a></p>\n        <p>Психиатры: <a href=\"https://www.who.int/healthinfo/universal_health_coverage/report/2017/en/\">https://www.who.int/healthinfo/universal_health_coverage/report/2017/en/</a></p>\n        <p>Хирурги: <a href=\"http://apps.who.int/gho/data/node.main.HWF9?lang=en%20\">http://apps.who.int/gho/data/node.main.HWF9?lang=en</a> </p>\n        <p>(данные здесь были дополнены из предыдущих редакций баз данных)</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Используя имеющиеся данные, показатель рассчитывается путем первого отдельного пересчета коэффициентов плотности медицинских работников для каждой из трех групп специальностей (врачи, психиатры и хирурги) относительно минимальных наблюдаемых значений в странах ОЭСР с 2000 года, которые выглядят следующим образом: врачи = 0,9 на 1000, психиатры = 1 на 100000, хирурги = 14 на 100000. Это изменение масштаба выполняется так же, как и для показателя плотности больничных коек, описанного выше, в результате чего значения показателя находятся в диапазоне от 0 до 100 для каждой из трех групп специальностей. Например, используя страновые данные по врачам на 1000 человек населения (<em> x </em>), показатель для конкретных групп будет рассчитан как:</p>\n        <p>Страна с x <0,9 на 1000 в год, групповой показатель = x / 0,9 * 100 </p>\n        <p>Страна с x> = 0,9 на 1000 в год, групповой показатель = 100</p>\n        <p>На заключительном этапе вычисляется среднее геометрическое значение трех показателей для конкретных групп специальнотей, чтобы получить окончательный показатель плотности работников здравоохранения.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>\"Врачи\" В идеале категорию можно было бы расширить, включив в нее всех \"основных медицинских работников\", таких как медсестры и акушерки. Однако не существует сопоставимой на международном уровне базы данных, в которой использовались бы последовательные определения основных медицинских работников, не являющихся врачами, для проведения полностью совпадающих сравнений между странами. </p>\n         <p> Для стран, у которых нет данных наблюдений, плотность хирургов была оценена с помощью регрессии, которая прогнозирует логарифм количества хирургов на 100000 человек, полученный из базы данных ВОЗ, описанной выше, как функцию логарифма значения ВВП на душу населения по оценке Всемирного банка</p>\n      </td>\n    </tr>\n  </tbody>\n</table>\n<table>\n  <tbody>\n    <tr>\n      <td>\n        <p>Область контроля</p>\n      </td>\n      <td>\n        <p>Безопасность здоровья</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Определение показателя</p>\n      </td>\n      <td>\n        <p>Индекс основных возможностей Международных медико-санитарных правил (ММСП), который представляет собой средний процент атрибутов 13 основных возможностей, которые были достигнуты в определенный момент времени </p>\n         <p> К 13 основным возможностям относятся: (1) Национальное законодательство, политика и финансирование; (2) Координация и общение с национальными координаторами; (3) Санэпиднадзор; (4) Ответ; (5) Готовность; (6) Информирование о рисках; (7) Человеческие ресурсы; (8) Лаборатория; (9) Пункты въезда; (10) Зоонозные явления; (11) Пищевая безопасность; (12) Чрезвычайные происшествия с отравляющими веществами; (13) Радиоизотопные аварийные ситуации.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Числитель</p>\n      </td>\n      <td>\n        <p>Количество достигнутых атрибутов</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Знаменатель</p>\n      </td>\n      <td>\n        <p>Общее количество атрибутов</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Основные источники данных</p>\n      </td>\n      <td>\n        <p>Обследование ключевых информаторов</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод измерения</p>\n      </td>\n      <td>\n        <p>Ключевые информаторы отчитываются о достижении набора атрибутов для каждой из 13 основных возможностей с использованием стандартного инструмента ВОЗ, как описано здесь: <a href=\"http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf\">http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf</a></p>\n        <p>Значения показателя уровня возможности можно найти здесь: </p>\n        <p><a href=\"http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en\">http://apps.who.int/gho/data/node.main.IHRSPARALL?lang=en</a></p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Метод оценки</p>\n      </td>\n      <td>\n        <p>Показатель рассчитывается путем усреднения по 13 основным возможностям, доля атрибутов для каждой достигнутой возможности.</p>\n      </td>\n    </tr>\n    <tr>\n      <td>\n        <p>Примечания, относящиеся к ВОУЗ</p>\n      </td>\n      <td>\n        <p>Страны начали отчитываться в ВОЗ о достижении основных возможностей по Международным медико-санитарным правилам (ММСП) за 2010 год. Для 2000-2009 годов используются самые ранние из имеющихся баллов по ММСП для каждой страны.</p>\n      </td>\n    </tr>\n  </tbody>\n</table>"}}